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Summary
Biosynthesis of vitamin B6 is essential for all living cells. Most organisms use
the pyridoxal 5’-phosphate (PLP) synthase complex to synthesize the cofactor
form, PLP, from the three substrates ribose 5-phosphate (R5P), glyceraldehyde
3-phosphate (G3P) and ammonia. PLP synthase complex is a glutamine amido-
transferase (GATase) class I, consisting of 12 Pdx1 and 12 Pdx2 subunits. Pdx1
is responsible for the PLP synthesis and Pdx2 is the glutaminase that hydroly-
ses glutamine to produce ammonia, which is transfered to the Pdx1 active site.
In this PhD Thesis, studying Pdx1 and Pdx2 proteins from the human parasite
Plasmodium falciparum and from the rodent parasite Plasmodium berghei gave
important insights into the assembly, activation and substrate tunneling of the
PLP synthase complex.
Electron microscopy analyses showed that association of the PLP synthase and
glutaminase subunits was random, suggesting a non cooperative mechanism in-
dependent of neighboring Pdx1 binding sites to be occupied by Pdx2. Complex
assembly is critical for glutamine hydrolysis by Pdx2, although the presence of
an ammonia acceptor in the Pdx1 active site did neither enhance the Pdx1/Pdx2
interaction nor the catalytic rate of Pdx2 in vitro, as tested by biophysical and
kinetic experiments. In particular, the PLP synthase complex does not show
allosteric activation by R5P or glutamine binding that would result in syn-
chronization of the glutaminase and PLP synthesis reactions. Therefore, the
Pdx1/Pdx2 interaction is enough to stimulate glutamine hydrolysis.
A particular motivation of this Thesis was to crystallize the PLP synthase com-
plex from the malaria causing parasite, P. falciparum, for the potential use of
the 3D structure in drug design. However, the complex assembled into fibers
in vitro, induced by the Pdx1 subunit, making the crystallization trials of this
enzyme impossible. A chimeric complex formed by Pdx1 from P. berghei and
Pdx2 from P. falciparum proved to be a catalytically active system, suitable
for structural studies of the plasmodial complex. Crystal structure of this en-
zyme complex gave two major advances in the understanding how prokaryotic
and eukaryotic PLP synthase complexes resemble each other or differ in pro-
tein interaction and activation. Variations at the Pdx1/Pdx2 interface occur
through insertion sequences in eukaryotic systems, notably in the plasmodial
PLP synthase complex by the loop 95-111 in Pdx2. Activation of the gluta-
minase is highly conserved in both systems. The process entails reorganization
of structural regions at the Pdx1/Pdx2 interface through stabilization of αN
and the oxyanion hole region. Activation of the PLP synthase requires a helical
segment, named α2’, for sugar binding. The helix is observed in two alternative
positions in the Pdx1/Pdx2 and Pdx1-R5P structures: an open conformation to
allow the entrance of the substrate and a closed conformation oriented towards
R5P, sequestering the substrate in the catalytic center. The pentose substrate
is bound in the P1 site to the catalytic Lys84 via a Schiff base with the ribose
C1 atom.
GATases are characterized by two separate active sites for glutamine hydro-
lysis and enzyme-specific metabolite syntheses. Previously, ammonia transfer
between two catalytic centers was proposed to occur by flexible methionine
residues within a transient tunnel in Pdx1. The plasmodial proteins show an
ammonia tunnel distict from bacterial orthologs as some of the residues lining
the passage are exchanged. Biochemical analysis confirmed that the (α/β)8-
barrel of Pdx1 passes the reactive ammonia produced in Pdx2 to Pdx1 active
site, assigning function of key residues for the ammonia channeling.
The differences between eukaryotic and prokaryotic systems provide insight into
PLP synthase complex regulation, which may be exploitable in drug design for
the treatment of malaria.
Zusammenfassung
Die Biosynthese von Vitamin B6 ist wichtig fu¨r alle lebenden Zellen. Die meis-
ten Organismen nutzen den Pyridoxal 5’-phosphat (PLP) Synthase Komplex
um den PLP Cofaktor aus den drei Substraten Ribose-5-Phosphat (R5P), Gly-
ceraldehyd 3-Phosphat (G3P) und Ammoniak zu bilden. Der Enzyme-Komplex
ist eine Glutamin Amidotranstransferase (GATase) der Klasse I, bestehend
aus 12 Pdx1 und 12 Pdx2 Untereinheiten. Pdx1 ist verantwortlich fu¨r die
PLP-Synthese und Pdx2 ist eine Glutaminase, die Glutamin zu Ammoniak
hydrolysiert um es auf Pdx1 zu u¨bertragen. In dieser Doktorarbeit geht es
im Wesentlichen um das Studium der Pdx1 und Pdx2 Proteine aus dem men-
schlichen Parasiten Plasmodium falciparum und dem Mausmalaria Parasiten
Plasmodium berghei. Diese Studie gibt dabei wichtige Einblicke u¨ber Aufbau,
Aktivierung und Substrat-Tunneling des PLP-Synthase-Komplex.
Elektronen mikroskopische Analysen zeigten, dass die Komplexbildung zwischen
Pdx1 PLP-synthase und Pdx2 Glutaminase Untereinheiten eher zufa¨llig abla¨uft,
was auf einen nicht kooperativen Mechanismus hindeuted, der unabha¨ngig davon
ist, ob benachbarte Bindungsstellen am Pdx1-Ring von Pdx2 Untereinheiten be-
setzt sind. Die Komplexformierung ist entscheidend fu¨r die Glutamin-Hydrolyse
durch Pdx2, obwohl die Anwesenheit eines Ammoniumionakzeptors im aktiven
Zentrum von Pdx1 weder zu einer Zunahme der Pdx1/Pdx2 Interaktion noch
der Pdx2 katalytische Rate fu¨hrt, was durch biophysikalische und kinetische
Experimente belegt ist. Insbesondere weist der PLP-Synthase-Komplexe keine
allosterische Aktivierung durch R5P- oder Glutamin- Bindung auf, was in einer
Synchronisierung der Glutaminase- und der PLP-Synthese-Reaktionen resul-
tieren wu¨rde. Demzufolge ist die Pdx1/Pdx2 Interaktion ausreichend un die
Glutamin Hydrolyse zu stimulieren.
Eine besondere Motivation dieser Doktorarbeit war die Kristallisation des PLP
Synthase-Komplex aus dem Malaria-Parasiten P. falciparum aufgrund seines
potentiellen Einsatzes im Drug-Design. Allerdings aggregiertete der Komplex
zu Fasern in vitro, induziert durch die Pdx1 Untereinheit. Die Kristallisation
der PLP Synthase war deshalb nicht erfolgreich. Ein chima¨rer Komplex gebildet
aus Pdx1 von P. berghei und Pdx2 von P. falciparum erwies sich als katalytisch
aktives System, geeignet fu¨r strukturelle Untersuchungen am Plasmodium Kom-
plex. Die Kristallstruktur liefert zwei bedeutende Beitra¨ge zum Versta¨ndnis
daru¨ber, wie sich prokaryotische und eukaryotische PLP-Synthase-Komplexe in
Proteininteraktion und -aktivierung a¨hneln oder unterscheiden. Variationen der
Pdx1/Pdx2 Interaktion treten durch die Anwesenheit von Insertionssequenzen
in eukaryotischen Systemen auf. In Plasmodium PLP Synthase-Komplexen ist
die Loop-Region 95-111 in Pdx2 an der Komplexbildung beteiligt, welche in bak-
teriellen Pdx2 Enzymen deletiert ist. Die Aktivierung der Glutaminase ist in
beiden Systemen hoch konserviert: eine Umordnung struktureller Regionen am
Pdx1/Pdx2 interface fu¨hrt zu einer Stabilisierung von αN und der Oxyanion-
Region. Die Aktivierung der PLP-Synthase erfordert ein helicales Segment,
genannt α2’, fu¨r die Bindung von Zucker moleku¨len, welches an zwei alterna-
tiven Positionen beobachtet wird: die offene Konformation in der Pdx1/Pdx2
Struktur erlaubt eine offene Konformation den Zugang fu¨r Substrate; dagegen
wird in der Struktur des R5P Substrat Komplexes eine geschlossene Konforma-
tion beobachtet, die das Substrat im katalytischen Zentrum sequestriert. Das
Pentose Substrat wird an der P1 Stelle des katalytischen Lys84 u¨ber eine Schiff-
Base an das C1-Atom der Ribose gebunden.
GATases haben zwei separate aktive Zentren, eines fu¨r die Ammoniak Produk-
tion und eines fu¨r die Synthese Aktivita¨t. Ein Modell des Ammoniak Trans-
fers vermittelt durch flexible Methioninaminosa¨uren innerhalb eines transienten
Kanals in Pdx1. Hier wird gezeigt, dass bei Plasmodien Proteinen einige der
Reste dieses Kanals ausgetauscht sind. Die biochemische Analyse besta¨tigte,
dass das (β/α)8-Barrel Ammoniak von Pdx2 zu Pdx1 transferiert. Durch Mu-
tagenese Analysen wurde den Aminosa¨uren eine Funktion im Ammoniak - Cha-
nneling zugewiesen.
Die Unterschiede zwischen eukaryotischen und prokaryotischen PLP-Synthase
Systemen erlauben Einblicke in Enzymregulierung, welche fu¨r das Drug Design
fu¨r die Behandlung von Malaria nutzbar sind.
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Chapter 1
Introduction
In living cells, many biochemical reactions catalyzed by enzymes take place
with the support of nonprotein components, called coenzymes or cofactors.
They fulfill crucial chemical steps required for a succesful enzymatic cataly-
sis. Cells contain different types of cofactors classified as organic molecules such
as biotin, nicotinamide adenine dinucleotide, thetrahydrofolate, thiamine py-
rophosphate, etc., and inorganic ions such as, Mg2+, Fe2+, Mn2+, Zn+2, etc.
Cofactor biosynthesis is essential for all living organisms because many enzymes
reactions depend on at least one cofactor. However, cofactors are not assembled
by the ribosome, rather by biosynthetic enzymes and here I focus on Vitamin
B6 biosynthesis.
Vitamin B6 is composed by six vitamers with a common pyridinium ring, whose
members are pyridoxal (PL), pyridoxamine (PM), pyridoxine1 (PN) and their
respective phosphorylated forms: pyridoxal 5’-phosphate (PLP), pyridoxamine
5’-phosphate (PMP) and pyridoxine 5’-phosphate (PNP). Of these compounds,
only PLP and PMP are the biologically active forms, while the others function
as PLP precursors. Their chemical structures are shown in Figure 1.1.
Vitamin B6 in the form of PLP has diverse functions in a large number of en-
zymes, the mayority of them catalyze reactions for the amino acid metabolism.
PLP serves as a transient carrier of specific functional groups in different reac-
tions at the α, β and γ carbons of amino acids. Examples of PLP-dependent
reactions are decarboxylations, racemizations, α, β-elimination and transamina-
tions. Pyridoxal 5’-phosphate is commonly bound through an aldimine (Schiff
base) linkage to the ε-amino group of a lysine residue in the active site of the
PLP-dependent enzyme.
As a common role of PLP in many transamination reactions, a general view
of the catalytic process is depicted in Figure 1.2. The aldehyde group of PLP
can accept an amine via a Schiff base with the amino acid. A highly unstable
1also known as pyridoxol
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Figure 1.1: Vitamin B6 compounds. Six alternatives of vitamin B6: pyridoxine, pyri-
doxamine, pyridoxal and phosphorylated forms pyridoxine-5’phosphate, pyridoxamine-5’
phosphate and pyridoxal-5’phosphate.
carbanion is avoided because the electron charge at the α-carbon is reduced by
resonance stabilization in the pyridinium ring of PLP (aldimine). In all trans-
amination, racemization and carboxylation reactions, a quinonoid intermediate
is formed, where the bond between the amine α-carbon to the adjoining func-
tional group - a side chain of an amino acid, a hydrogen, or a carboxyl - weakens
and consequently breaks. The products in each of the routes, transamination,
racemization, and carboxylation, are an α-ketoacid and PMP, a D-amino acid,
or an amine, respectively. The reverse transformation of PMP into PLP can
occur when the amino group is donated to an α-keto acid.
PLP is a very diverse functional cofactor, it also participates in reactions re-
quired for glycogen breakdown, formation of several amines functional in ner-
vous tissue (e.g., epinephrine, serotonin or norepinephrine), hemoglobin biosyn-
thesis and sphingolipid synthesis. Besides the important role as a cofactor, PLP
has antioxidant function against reactive oxygen free radicals [1, 2].
1.1 Pyridoxal 5’-phosphate biosynthesis
Enzymes for de novo biosynthesis of vitamin B6 are found in some organisms,
i.e., archaebacteria, bacteria, some protists, fungi and plants [3], while other
organisms like humans must obtain it from the diet. Vitamin B6 in the form
of PNP or PLP as the active form can be synthesized directly by two distinct
de novo routes: the deoxyxylose 5’-phosphate (DXP)-dependent and ribose 5-
phosphate (R5P)-dependent2 pathways, respectively (Figure 1.3). Both routes
contain highly conserved genes, but comparison of the encoded proteins shows
they are different in the amino acid sequence, suggesting that the two pathways
diverged during evolution. In addition to the de novo PLP biosynthesis, PLP
2also found in the literature under the name DXP-independent pathway
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Figure 1.2: PLP reaction with a general amine. a) A general reaction catalyzed by
PLP at the α-carbon (colored blue) of an amine: the Schiff base linkage between PLP
and the amino acid is stabilized by resonance with the pyridine nitrogen in PLP, forming
a quinonoid intermediate. b) PLP bound to a lysine through a Schiff base at the active
site: an amino acid substrate enters the active site and condenses to PLP via a new
Schiff base (not shown). In a aminotransamination reaction, PLP accepts the amine,
forming an α-ketoacid and PMP. Conversion of PMP into PLP is reversible, by donation
of the amino group to an α-keto acid. The alternative racemization and carboxylation
reactions give rise to a D-amino acid and amine, respectively. R and P stem from a
functional group and phosphate ion.
can be synthesized from precursors in the form of PL, PN, PM, PNP and PMP
that are converted to PLP in the so-called salvage pathway. This pathway func-
tions mainly as the recycling and interconvertion of the B6 vitamers by several
kinases and phosphatases present in the known proteome of living organisms,
as well as, by transaminases and oxidases, Figure 1.3.
1.1.1 The DXP-dependent pathway
The DXP-dependent pathway is found in a subset of the γ-division of proteobac-
teria and in the well characterized gram-negative bacterium, Escherichia coli [4].
The mechanism is divided into two steps for the synthesis of 4-phosphohydroxy-
L-threonine (4-HTP) and deoxyxylulose 5-phosphate (DXP) that converge in
a last step to form PNP. Three enzymes PdxA, PdxB and PdxJ are unique
for the de novo PNP biosynthesis. The initial step requires D-Erythrose 4-
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Figure 1.3: PLP biosynthesis. The three routes to synthesize PLP: two de novo routes
DXP-dependent and R5P-dependent for the synthesis of PNP and PLP, respectively;
and the salvage pathway, in which the B6 vitamers PN, PNP, PM, PMP and PL are
converted to PLP. See § 1.1 for more details.
phosphate and glutamate as substrates to produce 4-HTP in sequential steps
carried out by the enzymes GapA, PdxB and PdxF. 4-HTP is decarboxylated
by PdxA to form 3-hydroxy-1-aminoacetone phosphate (AAP), a very unsta-
ble intermediate. DXP is synthesized from pyruvate and G3P by the enzyme
DXPS. The process is finalized by PdxJ, which catalyses the cyclization of DXP
and AAP to produce PNP and Pi, Figure 1.3. PNP can be oxidised to form
PLP by an enzyme of the salvage pathway, PdxH, Figure 1.3.
1.1.2 The R5P-dependent pathway
Genes encoding proteins involved in the R5P-dependent pathway were first iden-
tified in Cercospora nicotianae [5, 6], when investigating the resistance mecha-
nism of the plant fungus against oxydative stress. From this study, a novel de
novo pyridoxine biosynthesis pathway was found to be commonly distributed
whithin some bacteria, archaea and many eukaryotes, including plants and fungi.
5The pathway consists only of two enzymes: Pdx1 and Pdx2. The three substra-
tes R5P, glyceraldehyde 3-phosphate (G3P) and glutamine are required for di-
rect PLP biosynthesis3. The heterocyclic nitrogen of PLP is derived through
hydrolysis of L-glutamine by Pdx2 [7, 8], Figure 1.3
1.2 The glutamine amidotransferase Pdx1 and
Pdx2 complex
Most of the reactions in the biosynthesis of amino acids, nucleotides and coen-
zymes are catalyzed by enzymes which use glutamine as ammonia source, called
glutamine amidotransferases (GATases). GATases have two structural domains:
a glutaminase, where ammonia is produced from glutamine and a synthase do-
main, which binds the ammonia acceptor substrate. There are two types of
GATases: class I 4 and class II 5 GATases [9]. Both class of enzymes carry
out the same catalytic reaction, using a conserved cysteine residue in the glu-
tamine binding site. The two classes of GATases differ in the way they use the
nucleophilic cysteine: GATases class I use histidine and glutamate residues to
activate the thiol group of cysteine; and in GATases class II the cysteine residue
is positioned at the N-terminus and is activated by its α amino group [9]. The
thiol group of the cysteine becomes highly nucleophilic by its interaction with
the imidazol-N of the His residue and can attack the γ carbonyl of glutamine,
producing ammonia and glutamate. This reaction results in the formation of
a negatively charged transition state with tetrahedral geometry in the active
site of the glutaminase, Figure 1.4. This transition state is stabilized by hydro-
gen bonds oriented to form a pocket called oxyanion hole (OXH), critical for
glutamine hydrolysis. The ammonia produced in this reaction is subsequently
transfered through an ammonia tunnel to the synthase domain, where it reacts
with the acceptor substrate to form the aminated product. An example is the
imidazole glycerol phosphate (ImGP) synthase [10], a key enzyme required to
link amino acid and nucleotide biosynthesis. The PLP biosynthetic Pdx1 and
Pdx2 proteins assemble into glutamine amidotransferase type I enzyme with
Pdx1 as the PLP synthase and Pdx2 as the glutaminase [11, 12]. A proposed
mechanism for class I GATases is depicted in Figure 1.4.
1.2.1 Pdx1/Pdx2 interaction
The x-ray crystallographic structure of the PLP synthase complex has been ob-
tained so far from the bacteria T. maritima (PDB code 2ISS, [13]) and B. subtilis
(PDB code 2NV2, [14]). The Pdx1/Pdx2 complex builds a 24-mer multienzyme,
consisting of each subunit of the dodecameric Pdx1 core in independent inter-
action with one Pdx2 subunit. Pdx1 and Pdx2 active sites are far from each
3the chemical reaction is explained in more detail in § 3.5
4also named triad GATases
5also named N-terminal nucleophile (Ntn)
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Figure 1.4: Proposed mechanism for class I glutamine amidotransferases. The GATase
has two domains: glutaminase and ammonia acceptor. The glutaminase binding domain
contains conserved Cys, His and Glu traid residues required for catalytic reaction to the
Gln. The thiol group of Cys (green) attacks the amide group of Gln and the γ-amido
nitrogen is released as NH3 (red). A glutamyl-enzyme intermediate is formed at the
γ-carbon with tetrahedral geometry. An oxyanion is stabilized by hydrogen bond from a
peptide element in the active site. The produced NH3 is transfered to the active site of
the acceptor domain through a channel, where it reacts with an NH3-acceptor susbtrate.
Glutamate and water are the products of the glutamine hydrolysis, while an aminated
product is synthesized in the NH3 acceptor domain.
other with a distance of ∼22 A˚. As a glutamine amidotransferase enzyme, Pdx2
hydrolyses glutamine and the produced NH3 in this reaction is subsequently
transferred through an ammonia channel to the second active site in Pdx1. It
was postulated earlier the ammonia channel localizes inside the (β/α)8-barrel
of Pdx1 and is lined by flexible methionines [14].
The Pdx1 and Pdx2 interaction was suggested to entail ordering of the helix αN
from Pdx1, a helix embeded between the two subunits and is in close proximity
to the Pdx2 active site. Helix αN plays a key role in heterodimer formation and
activation of Pdx2 [14, 15]. The Pdx1/Pdx2 complex involves also organization
of the oxyanion hole in Pdx2 by reorientation of two peptides of amino acid
residues Pro45-Gly46-Gly47 (nomenclature for B. subtilis Pdx2) [16], when the
two subunits interact with each other, Figure 1.5.
1.2.2 The R5P-dependent PLP synthase: Pdx1 with
multiple enzymatic reactions
Most of the 3D crystallographic structures of the PLP synthase complex are from
the Pdx1 subunit. They are from several prokaryotic organisms such as, Bacil-
lus subtilis (PDB code 2NV1, [14]), Geobacillus stearothermophilus (PDB code
1ZNN, [17]), Methanocaldococcus jannaschii (PDB code 2YZR) and Thermus
thermophilus (PDB code 2ZBT). The current availabe eukaryotic Pdx1 struc-
7Figure 1.5: Active site and activation of Pdx2. The active site in Pdx2 alone (orange,
PBD entry 2NV0, [14]) and in the Pdx1/Pdx2/Glutamine complex (pink, PDB entry
2NV2, [14]) from Bacillus subtilis. The triad catalytic is shown in sticks: C79, H170
and E172. H170 residue was replaced by Asn in Pdx2 to stabilize the Pdx1/Pdx2/Gln
complex for crystallization [14]. Reorientation of the residues Q10 at loop β1-α1 and
E48 implicated in glutaminase activity and complex formation with Pdx1 [16] are shown
in sticks. Dashed lines represent the two peptide flip of P45-G46-G47. Two potential
hydrogen bonds are shown in green dots: for tetrahedral intermediate (between the
sulphydryl of C79 and the γ-carbonyl of Gln) and for stabilization of the oxyanion hole
(the O of the Gln amide group and the N of the G47 peptide bond). Part of the Pdx1
α-N is displayed.
ture is from Saccharomyces cerevisiae (PDB code 3FEM, [18]). Sequence con-
servation is mainly observed among Pdx1 proteins with up to 40% identity (see
Alingnment D.1).
The Pdx1 monomer has a (β/α)8 fold with the location of the active site at
the C-terminus of the β-barrel, common in enzymes with this fold [19, 20].
Additional helices and loops surround the (β/α)8 core. The bacterial Pdx1
complex has 12 Pdx1 monomers, forming two hexameric rings that dimerise to
build a dodecameric core [17, 14]. The protein exists in solution in a hexamer-
dodecamer equilibrium. The yeast Pdx1 forms mainly hexamers in solution and
the x-ray crystallographic structure has shown the same oligomeric state [18].
Assembly to the dodecamer is mediated by helix α6 and two additional helices,
α6’ and α6”, which protrude from the globular architecture of the (β/α)8 barrel.
The dodecameric interface in the yeast Pdx1 is disturbed by a lysine residue
at the α6-α6” loop absent in other Pdx1 proteins. The implication of this
amino acid residue insertion in Pdx1 for enzyme activation and regulation in
the hexameric core of the yeast Pdx1 is unknown at present.
Pdx1 uses R5P and G3P and condenses the two phosphorylated sugars and
ammonia (NH3) from L-glutamine to synthesize directly PLP. The biochem-
istry of Pdx1 comprises several reactions described recently by Hanes et al 2008
8[21], Figure 1.6. The proposed mechanism suggests that Pdx1 binds the pen-
tose R5P ring, forms an imine between the R5P aldehyde and a lysine in the
active site, isomerizes it to ribulose 5-phosphate (Ru5P), incorporates nitrogen
from glutamine to the carbon 5 of the Ru5P backbone by an imine formation,
performs tautomerization, amine elimination, phosphate ion elimination, G3P
incorporation, imine hydrolysis and cyclization to form the pyridinium ring,
PLP. Incorporation of ammonia to the R5P adduct leads to the formation of
a stable chromophoric intermediate I320 with maximum absorbance at 315 nm
[22], used commonly to analyse the enzymatic activity of Pdx1 by spectrophoto-
metric experiments. Noteworthy, Pdx1 has the ability to prescind from Pdx2 in
vitro and synthesize PLP using other NH3 sources such as, NH4Cl or NH2SO4.
There are not cell biology data available to explain whether Pdx1 takes ammo-
nia from the cellular environment or from glutamine hydrolysis in Pdx2 or both.
However enzymatic studies in vitro have shown that Pdx2 enhances PLP syn-
thesis in Pdx1 [23], suggesting domain comunication is important for catalysis.
Figure 1.6: Proposed reaction mechanism for PLP biosynthesis via the R5P-dependent
route from Hanes et al 2008 [21]. See text § 1.2.2
1.2.3 Pdx2: the glutaminase of the PLP synthase complex
Known structures of the Pdx2 subunit are solved from B. subtilis (PDB codes
1R9G[11], 2NV0[14]), G. stearothermophilus (PDB code 1Q7R, [17]), T. ther-
9mophilus (PDB code 2YWD) and P. falciparum (PBD code 2ABW, [24]). Pdx2
is a Rossmann-fold protein with a α/β layer structure common to other members
of triad glutamine amidotransferases. Pdx2 is highly variable and insertion se-
quences are common in eukaryotic homologues with aproximately 35% identity
between bacterial and eukaryotic Pdx2 proteins. The eukaryotic Pdx2 struc-
ture from P. falciparum has structural segments different to the bacterial Pdx2
and was proposed that some of them are possibly involved in protein-protein
interaction with Pdx1 [24].
Pdx2 as the NH3 donor in the PLP synthase complex, has an enzymatic center
constituted by the catalytic triad: cysteine, histidine and glutamate (see align-
ment, Figure D.2) for glutamine hydrolysis, as explained above § 1.2. Pdx2
is functional when interacting with Pdx1, as a manner to control glutamine
hydrolysis and therefore optimize glutamine use. Whether Pdx2 activation re-
lies simply on Pdx1 interaction or requires an NH3 acceptor bound in the active
site of Pdx1 is not known at present.
1.3 Current knowledge of PLP biosynthesis in
malaria parasites
Plasmodia are protozoan parasites member of the phylum apicomplexa and
responsible for the protozoal disease, Malaria. It is estimated approximately
1 million death anually occurs due to malaria in several countries of Africa,
Asia and Latin America [25], caused mainly by Plasmodium falciparum.
1.3.1 The elaborate life cycle of Plasmodium
Plasmodium species have a complex life cycle involving two hosts, the vector
Anopheles mosquito and vertebrates such as, humans, rodents, monkeys, etc.
The most studied malaria-causing parasite is P. falciparum. It develops with
several morphological stages in the mosquito and human hosts, each having
an asexual proliferation and invasive stage, named sporozoite and merozoite,
respectively. To complete its life cycle, P. falciparum has a sexual stage shared
between both hosts, in which gametes produced in the human are fertilized in the
mosquito. Different morphologies of the parasite grow in the erythrocytes: ring,
trophozoite, schizont, gametocyte and merozoite, causing a notable necessity for
nutrients. In consequence of constant feeding by the parasite, the infected host
cells degenerate and release the merozoites into the bloodstream, where they can
invade other red blood cells and gametocytes can be taken up by a mosquito
during feeding (Figure 1.7, A).
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Figure 1.7: The complex life cycle of Plasmodium falciparum. A) the sexual cycle of
the parasite is developed in the mosquito and human hosts. Two asexual proliferative
stages are invasive: merozoites and sporozoites. B) a model for the de novo PLP biosyn-
thesis and hypothetical transport of dephosphorylated B6 vitamers into the parasite is
described in a parasite infected-erythrocyte: direct supply of PLP would occur by the
R5P-dependent route and/or hemoglobin (Hb) uptake. Dephosphorylated PL, PN, PM
vitamers in the red-blood cell would be transported into the parasite and converted into
PLP by proteins of the salvage pathway PdxK, transaminases and oxidases. See § 1.1
for more detail of the enzymes involved in the PLP biosynthesis pathways.
1.3.2 Plasmodial PLP biosynthesis in the red blood cell
During intraerythocytic stages, the parasite needs proper survival mechanisms
to adapt under different host conditions. Due to the importance of PLP as
an essential enzyme cofactor, Plasmodium must obtain it and supply cellular
PLP demands. P. falciparum ingests and degrades more than 75% of the host
cell hemoglobin in the acidic vacuole [26] for protein biosynthesis and energy
generation [27]. It is known that hemoglobin binds PLP and PL [28] and might
serve as a PLP source. However, there are not evidence to date which show the
erythrocytes contribute in parasite nutrition in regards to vitamin B6.
The B6 vitamers in the form of PN and PM, as well as their phosphorylated
forms would require to be converted to PL in the erythrocyte before delivered
to the parasite, because human homologues of PNP and PMP oxidases have not
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been identified yet in the genome of Plasmodium, suggesting that transamination
of pyridoxamine 5’-phosphate and oxidation of pyridoxine 5’-phosphate to form
PLP might not be possible in the parasite. Therefore PL and/or PLP might be
the mayor B6 vitamers in Plasmodium (Figure 1.7, B).
The pdx1 and pdx2 genes encoding enzymes of the R5P-dependent pathway are
found in Plasmodium [29]. Both genes lack a signal targeting sequence. Their
protein expression profile in the intraerytrocytic stages of P. falciparum shows
that Pdx1 and Pdx2 localize in the cytosol [24], suggesting the de novo PLP
biosynthesis in the parasite might be functional.
1.4 Aim of the PhD Thesis
Pdx1 and Pdx2 proteins from Plasmodium are chosen to make this PhD thesis,
to gain insights into enzyme function and regulation of the PLP synthase com-
plex, which can contribute in understanding the biology of PLP biosynthesis in
the malaria parasite.
The Doctoral thesis was focused on:
• Determination of the first eukaryotic 3D structure of PLP synthase com-
plex
• Insight into the malarial PLP synthase with a vision to drug design
• Study of the assembly of the PLP synthase complex
• Understanding of the mechanism of ammonia substrate tunneling
• Understanding of the PLP biosynthesis reaction mechanism based on
structural studies
PLP synthase complex assembly
The R5P-dependent PLP synthase assembles into a multi-enzyme of 24mers
with 12 PLP synthase and 12 glutaminase subunits. This high order of organi-
zation implies the enzyme is regulated to control enzyme function and activation
as a fully occupied complex. Pdx2 for instance enhances the R5P binding in
bacterial Pdx1 [18]. However, it is not known whether Pdx2 remains bound
to Pdx1 and dissociates from Pdx1 once ammonia is delivered or binding of
substrates regulate the Pdx1/Pdx2 assembly. This raises the question whether
PLP synthase complex functions as a full 24mer enzyme or Pdx2 transiently
interacts with Pdx1 to provide ammonia. In order to describe the assembly
process of the enzyme complex, the Plasmodium PLP synthase complex is anal-
ysed in the presence and absence of substrates, using electron microscopy and
isothermal titration calorymetry.
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The Pdx1/Pdx2 interface has been analysed in detail in B. subtilis [14, 16].
However, eukaryotic systems are not yet available to explain whether there
exist differences in the interaction mode between Pdx1 and Pdx2 of the PLP
synthase complex from both cellular types. Crystallization of the plasmodial
PLP synthase complex is pursued to compare how protein-protein interaction
in eukaryotic and prokaryotic PLP synthase complexes is built, based on x-ray
crystallographic studies.
Ammonia tunnel in the PLP synthase: a common geometry with
slight variations in the packing
A proposed model for ammonia shuttling in BsPdx1 suggested that methio-
nine residues would be involved in transfer of ammonia from Pdx2 to Pdx1
active site [14]. Although, not all methionines are conserved among Pdx1 pro-
teins, suggesting variations in the tunnel packing maintain a similar function
for ammonia delivery. Whether this difference is reflected in the regulation of
ammonia transfering is not known. To gain insight into the process of ammonia
transfer, residues of plasmodial Pdx1 are mutated by site directed-mutagenesis
and the resulting variant proteins are analysed by enzymatic assays. The bio-
chemical analysis should provide insights into the function of conserved and
variable residues, to understand ammonia uptake by Pdx1.
PLP synthase activation: views towards the mechanism of PLP
biosynthesis
The enzymatic reactions that lead to PLP synthesis in the R5P-dependent route
occur mainly in Pdx1. The reaction steps involve a chemistry described by
[21]. Participation of some residues in substrate binding and catalysis have
been characterized [17, 14, 13, 22, 30], providing important knowledge about
PLP biosynthesis. The enzyme requires structural regions to stabilize substrate
binding and activate PLP synthesis such as, the C-terminus and helix α2’. The
C-terminus plays a role in enzyme function, as seen by the depletion of PLP
synthesis in C-terminal deletion mutants of B. subtilis and S. cerevisiae Pdx1
[23, 18]. Helix α2’ orders, when Pdx2 interacts with B. subtilis Pdx1 and po-
sitions in the vicinity of the active site [14]. Crosslinking studies made in B.
subtilis Pdx1 suggested that R5P binding is a cooperative process, described by
intra-subunit comunication between neighboring subunits [23]. Contributions
to understand the role of the Pdx1 C-terminus in enzyme regulation were made
by deleting this segment in P. berghei Pdx1 and dissecting it in various regions
in P. falciparum Pdx1 (published in [31]). Additionally, activation and reaction
mechanism of the PLP synthase is investigated, using Pdx1 structures in the
presence and absence of substrates, as well as in complex with Pdx2 to allow
understanding how structural elements such as helix α2’ are required for R5P
binding and how catalytic residues react with the substrates to produce PLP.
Chapter 2
Materials and Methods
Chemicals. L-Glutamic Dehydrogenase from bovine liver, 3-acetylpyrimidine
adenine dinucleotide, D-Ribose 5-phosphate, DL-glyceraldehyde 3-phosphate,
L-Glutamine, Glycine, Tris, NaCl, Dithiothreitol (DTT) were from Sigma -
Aldrich Vienna - Austria. Imidazol was from Merck Darmstadt-Germany. KCl,
NaH2PO4 and EDTA were from ApliChem GmbH, Darmstadt-Germany. All
other chemicals and reagents were from Roth, Karlsruhe-Germany.
2.1 Molecular biology and protein expression
Heterologous Pdx1 and Pdx2 proteins from P. falciparum, P. berghei and the
archeabacteria Thermus thermophilus were used in this study. Vectors con-
taining the desired genes are listed in Table 2.1.
Gene cloning. The plasmodial pdx1 and pdx2 genes from P. falciparum 3D7
and P. berghei cDNA NK65 strains were cloned by M. Gengenbacher, Institute
for Hygiene, Heidelberg 2006 as described in [24]. The genes were inserted into
NdeI and XhoI restriction sites of the expression vectors pET21a or pET24a (No-
vagen, Darmstadt-Germany) using enzymes from New England BioLabs (NEB),
Frankfurt-Germany.
Point mutations in the wild-type pbpdx2 (H199N) and pbpdx1 (M19V, M46I,
L82A, L82S, L82F, L82M, M103A, M103F and M148L) genes were introduced
using the Quick change muthagenesis Kit (Stratagene, La Jolla, CA, USA).
The used primers are listed in Appendix A. Untagged P. falciparum Pdx1 and
Pdx2H196N constructs were created by PCR amplification using oligonucleotides
listed in Appendix A.
Gene encoding for full length T. thermophilus Pdx1 protein was amplified by
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Table 2.1: Clones and vectors used in this study. Clones marked with an asterisk ∗
were provided by PD Dr. Barbara Kappes, Institute for Hygiene, Heidelberg University.
Clone Vector Tag
Pf Pdx1∗ pET21a C-terminal 6His-tag
Pf Pdx2∗ pET21a C-terminal 6His-tag
Pf Pdx2H196N∗ pET21a C-terminal 6His-tag
PbPdx1∗ pET21a C-terminal 6His-tag
PbPdx2∗ pET24a C-terminal 6His-tag
Pf Pdx1-native pET21a -
Pf Pdx2H196N -native pET21a -
PbPdx2H199N pET24a C-terminal 6His-tag
PbPdx1M19V pET21a C-terminal 6His-tag
PbPdx1M46I pET21a C-terminal 6His-tag
PbPdx1L82A pET21a C-terminal 6His-tag
PbPdx1L82S pET21a C-terminal 6His-tag
PbPdx1L82M pET21a C-terminal 6His-tag
PbPdx1L82F pET21a C-terminal 6His-tag
PbPdx1M103A pET21a C-terminal 6His-tag
PbPdx1M103F pET21a C-terminal 6His-tag
PbPdx1M148L pET21a C-terminal 6His-tag
TtPdx1 pET21a C-terminal 6His-tag
PCR from genomic DNA of the T. thermophilus HB8 DSM 579 strain purchased
from “Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH”,
Germany. The ttpdx1 gene was cloned into BamHI and NotI restriction sites of
the PCR R©2.1-TOPO R© vector (Topo TA cloning kit, Invitrogen). After gene
sequencing, the ttpdx1 gene was excised from the TOPO vector using BamHI
(from NEB) and NotI restriction enzymes and further digested with NdeI. The
digested product was recloned into NdeI and NotI sites of the expression vector
pET21a.
Protein expression. All plasmodial proteins were expressed in Escherichia
coli BL21-Codon Plus (DE3)-RIL expression cell (Stratagene, USA) transformed
with cloned vectors. The TtPdx1 protein was expressed in E. coli BL21-Codon
Plus (DE3) expression strain (Stratagene, USA). Cells were grown in LB media
at 37◦C to an OD600 = 0.7 and then induced by addition of 0.1 mM IPTG for
3 hours. After induction, the cells were harvested by centrifugation at 4000xg
for 20 minutes at 4◦C, flash frozen in liquid nitrogen and stored at -20◦C.
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2.2 Protein purification
Cell disruption. Pellets from 1 liter expression culture were resuspended in 50
ml lysis buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM Imidazol). Cells
expressing untagged Pf Pdx1 and Pf Pdx2H196N proteins were resuspended in
200 ml buffer A (50 mM Tris pH 8.0, 10 mM NaCl, 1 mM EDTA, 5% glycerol,
0.5 mM MTG) and cells in suspension were disrupted using a microfluidizer,
MicrofluidicsTM (Newton, Massachusetss, United States). The cellular debris
was removed by centrifugation at 26000xg at 4◦C. The lysate from TtPdx1 was
incubated at 70◦C for 20 minutes and further centrifuged for 20 minutes at
26000xg at 4◦C.
1st purification step: Ni affinity for 6His-tagged proteins. Proteins
were purified by metal ion affinity chromatography using the Ni-Nitrilotriacetic-
acid beads from GE Healthcare, previously equilibrated with lysis buffer and
a flow rate of 1 ml/min. The column containing protein-bead mixtures was
washed with 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazol and
50 mM NaH2PO4 pH 8.0, 500 mM NaCl, 60 mM imidazol. Proteins were
eluted with elution buffer (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 250 mM
imidazol). Fractions containing the desired protein were concentrated using
Amicon R© Ultra filters (Millipore, Ireland) with 30 kDa and 10 kDa cutoff for
Pdx1 and Pdx2 proteins, respectively, and applied to a gel filtration column.
Purification of native proteins. Untagged Pf Pdx1 and Pf Pdx2H199N were
purified by anion exchange chromatography, using a self-packed XK26/20 col-
umn (GE Healthcare, Uppsala-Sweden) with 5 ml Source 30Q matrix (GE
Healthcare, Uppsala-Sweden) and equilibrated with buffer A. The lysate was
applied to the column and the column was washed with 3 column volumen
(CV) buffer A with a flow rate of 1 ml/min at 4◦C. Protein was eluted with a
salt gradient from 10 to 800 mM NaCl against buffer B (50 mM Tris pH 8.0,
800 mM NaCl, 1 mM EDTA, 5% glycerol, 0.5 mM MTG). The gradient volume
was 20 CV. Pf Pdx1 was detected in elution peaks containing 30 mM (peak
A), 220 mM (peak B), 410 mM (peak C), 500 mM (peak E) of NaCl (shown
in § 3.1.4). Pf Pdx2H196N eluted with 286 mM NaCl (Figure B.2). The frac-
tionated proteins from peak A for Pf Pdx1 or peak B for Pf Pdx2H196N were
concentrated using Amicon R© Ultra filters with 30 kDa for Pf Pdx1 or 10 KDa
for Pf Pdx2H196N and loaded onto a gel filtration column.
2nd purification step: size exclusion chromatography. For Pdx1 proteins,
a SuperdexTM 200 26/60 column (GE Healthcare) was used. The column was
equilibrated with gel filtration buffer (20 mM Tris/HCl pH 8.0, 200 mM NaCl,
1 mM EDTA, 0.5 mM MTG). The TtPdx1 gel filtration buffer contained 20
mM Tris pH 8.0, 200 mM KCl. For Pdx2 proteins, a SuperdexTM 200 26/60
column (GE Healthcare) equilibrated with 20 mM Hepes pH 7.0, 200 mM KCl,
0.5 mM MTG was used. The elution profiles for PbPdx1, PbPdx2 and Pf Pdx2
wild types were the same for PbPdx1 ammonia tunnel mutants, PbPdx2H199N
and Pf Pdx2H196N , respectively. Calibration of the gel filtration Superdex 200
26/60 column was done using the calibration standards from Bio-Rad (Bio-
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Rad Laboratories, Inc. United States) in the same gel filtration buffer used
for protein purification. The gel filtration standard components with respective
molecular masses were: Thyroglobulin (bovine) 670 kDa, γ-globulin (bovine)
158 kDa, Ovalbumin (chicken) 44 kDa, Myoglobin (horse) 17 kDa and Vitamin
B12 1.35 kDa.
Fractions containing the desired protein were pooled and concentrated for fur-
ther enzymatic, crystallization, electron microscopy and/or ITC experiments.
Protein concentrations were estimated by measuring the absorbance at 280 nm.
The predicted extinction coefficients for all proteins used were calculated with
the ProtParam Tool http://expasy.org/tools/protparam.html.
Complex formation analysis by size exclusion chromatography. Pu-
rified PbPdx1 and PbPdx2H199N proteins at a concentration of 0.15 mM were
mixed 1:1 ratio and further loaded on a Superose 6 10/30 (GE Healthcare) pre-
viously equilibrated with buffer 20 mM Tris/HCl pH 8.0, 200 mM NaCl, 1 mM
EDTA, 0.5 mM MTG. For the analysis of the chimeric PbPdx1/Pf Pdx2H196N
complex, proteins were mixed 1:1 molar ratio to a final concentration of ∼ 1 mM
in buffer 20 mM Tris/HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM MTG,
10 mM L-glutamine. Calibration of the gel filtration Superose 6 10/30 column
was done using the calibration standards from Bio-Rad (Bio-Rad Laboratories,
Inc.) as above, in gel filtration buffer 20 mM Tris/HCl pH 8.0, 200 mM NaCl,
1 mM EDTA, 0.5 mM MTG.
2.3 Enzymology
2.3.1 PLP synthase assay
The enzymatic activity for PLP synthesis was monitored spectrophotometrically
at λ = 414 nm (PLP= 5380 M
−1 cm−1) at 37◦C as described [22]. Purified
proteins were exchanged to reaction buffer 50 mM Tris/HCl pH 8.0, 20 mM
NaCl by centrifugation using Amicon R© Ultra filters with 30 kDa and 10 kDa
cutoff for Pdx1 and Pdx2 proteins, respectively. PLP synthesis from Pdx1 pro-
teins, including the PbPdx1 mutants (PbPdx1M19V , PbPdx1M46I , PbPdx1L82A,
PbPdx1L82S , PbPdx1L82M , PbPdx1L82F , PbPdx1M103A, PbPdx1M103F and
PbPdx1M148L) contained a reaction mixture of 40µM Pdx1, 1 mM R5P, 1 mM
G3P and 10 mM NH4Cl in a final volume of 300 µl. For Pdx1/Pdx2 complexes,
additionally 40µM Pdx2 was present, and NH4Cl was replaced by 10 mM L-Gln.
Measurements were carried out at 37◦C for four hours in 50 mM Tris/HCl, 20
mM NaCl pH 8.0.
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2.3.2 Glutaminase assay
The enzymatic activity for glutamine hydrolysis was analyzed using a coupled
enzyme assay with glutamate dehydrogenase described by [24]. The reaction
mixture contained 5µM Pdx1 or Pdx1 mutants, 5µM Pdx2, 10 mM L-Gln, 10
U glutamate dehydrogenase and 0.5 mM APAD+ in 50 mM Tris/HCl pH 8.0,
20 mM NaCl at a final volume of 300 µl. The reduction of APAD+ to APADH
was monitored at 363 nm (APADH= 8900 M
−1 cm−1) for 20 min at 30◦C.
2.4 Biophysical experiments
2.4.1 Isothermal titration calorimetry, ITC
Protein-protein interactions can be characterized by their heat generated or ab-
sorbed. ITC is a method that provides information of enthalpy ∆H◦, entropy
∆S◦ and Gibbs free energy ∆G◦ changes of any reaction under isothermal con-
ditions. In a single ITC experiment, two reactants are titrated against one an-
other generating (exothermic reaction) or absorbing (endothermic reaction) heat
during the molecular interaction. The binding constant Ka, enthalpy change
∆H and binding stoichiometry n can be determined by non-linear least squares
curve-fitting of the heat change per injection [32]. From the binding constant
Ka, the change in free energy of binding ∆G
◦ and entropy change ∆S◦ at con-
stant temperature can be calculated using the equation 2.1 and 2.2, where R is
the gas constant and T the temperature.
∆G◦ = −RTlnKa (2.1)
∆G◦ = ∆H − T∆S◦ (2.2)
In this work, complex formation between PbPdx1 or Pf Pdx1 with PbPdx2 or
Pf Pdx2 were analysed by ITC, using a VP-ITC Microcalorimeter (MicroCalTM,
Northampton, USA) as described before [15, 33]. Binding assays were done in
absence or presence of 1 mM L-Gln at 25◦C. All purified proteins were dialysed
overnight in buffer 20 mM Tris/HCl pH 8.0, 20 mM NaCl, 1 mM EDTA, 0.5 mM
MTG, +/- 1 mM L-glutamine. The experimental protocol used an initial 5µl
injection followed by 29 injections of 7µl of Pdx2, typically at a concentration
of 350 − 400µM, against a cell containing Pdx1, typically at a concentration
of 40µM. The binding heat was determined by integration of the areas under
the peaks, using the Origin 7.0 graphing/data analysis software [34]. The data
were corrected for buffer dilution heats, using measurements in which Pdx2 was
titrated into buffer.
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2.4.2 Analytical ultracentrigution, AUC
Association of the PbPdx1 and PbPdx2H199N in solution in the presence and
absence of R5P and L-glutamine were determined by hydrodynamic analysis
in analytical ultracentrifugation experiments using a Beckman Optima XL-A
ultracentrifuge equipped with absorbance optics and an An60 Ti rotor (Beck-
man Coulter, Fullerton, CA). Sedimentation velocity studies were carried out
at 42,000 rpm at 20◦C using proteins with absorbance of 1 at λ=280 nm. Cen-
trifugation was done in buffer 20 mM Tris pH 8.0, 20 mM NaCl, 1 mM EDTA,
0.5 mM MTG, +/- 1 mM R5P and +/- 1 mM L-glutamine.
Buffer density ρ and viscosity η were calculated using the program SEDNTERP,
Version 1.09 (University of New Hampshire). Sedimentation coefficients were
derived from the c(s) distribution of the raw data processed in Sedfit [35]. The
theoretical and expected molecular weights were calculated using the aminoacid
sequence with and without substrate(s) and from the molar mass distribution
using Sedfit [36, 35], respectively.
2.5 Crystallization and Structure determination
Fundamentals of X-ray diffraction
X-rays are electromagnetic waves with wavelengths in the order of atomic dis-
tances 0.1 nm = 1 A˚. The suitable x-rays used in crystallography are in the range
between 0.5 A˚ and 1.6 A˚, because the x-rays can interact and be scattered by
electrons of atoms in protein crystals [37]. Crystals contain molecule(s) within
a unit cell, which is periodically repeated in three dimensions. Interaction of
the incoming X-ray with the atom electrons produces X-ray scattering. The
conditions for constructive interference of scattered waves are given by Bragg’s
Law (equation 2.3):
nλ = 2dsinθ (2.3)
where n is integer, d the spacing distance between scattering planes, θ the
scattering angle and λ the wavelenght of the x-ray.
A reflexion for each set of parallel lattice planes is observed only if the dis-
tance d and θ between parallel lattice planes follow Bragg’s Law. The diffracted
beam produces spots, whose intensity I ∝ A2 can be measured by the detector.
However, the phase of the beam wave cannot be measured directly, because
detectors are sensitive only to the incoming energy and this energy is indepen-
dent of the wave phase. If the phases are known, the electron density of the
diffracting atoms in the unit cell can be obtained by Fourier Transformation.
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2.5.1 Protein crystallization and data collection
PbPdx1, PbPdx1-R5P, PbPdx1/PbPdx2H199N and PbPdx1/Pf Pdx2H196N and
TtPdx1 were crystallized by sitting or hanging drop vapor diffusion at 19◦C
under the conditions written in Tables 2.2. Crystals of PbPdx1 with R5P were
obtained by co-crystallization. Before setting drops, the protein was incubated
with 10 mM R5P in gel filtration buffer for 1 hour at room temperature. The
TtPdx1 crystals were soaked in mother liquor containing substrates as detailed
in Tables 2.2. Crystals were flash frozen in liquid nitrogen, using respective cryo-
protectants (Tables 2.2). Datasets were collected in the European Synchrotron
Radiation Facility in Grenoble, France. For complete data collection, optimal
starting angle and oscillation range were calculated using the ”Strategy” option
implemented in the software iMOSFLM graphical user interface [38].
PbPdx1 PbPdx1-R5P PbPdx1/
(ga48-3) (ga50-3) PfPdx2H196N (ga38-5)
Protein (mg/ml) 20 20 15
Beamline ID23-2 ID14-4 ID23-1
Crystallization 0.1 Bicine pH 8.5, 0.1 Bicine pH 8.5, 0.1 NaK/Phosphate
condition 1.6 M LiCl 1.2 M LiCl pH 6.2, 0.2 M NaCl,
6% PEG8000
substrate 10 mM R5P
added (mM) in the condition
Cryoprotectant 15 % glycerol 15% glycerol 20% EG
TtPdx1-R5P TtPdx1-PLP
(i6-2) (i20-5)
Protein (mg/ml) 30 30
Beamline ID29 ID14-4
Crystallization 0.1 MES pH 6.0, 0.1 NaAcetate pH 5.5,
condition 0.8 M LiCl, 0.2 M MgAcetate,
10% PEG6000 20% MPD
substrate 15 mM R5P 10 mM PLP
added (mM)
incubation 1 day 15 hours
time
Cryoprotectant 20 % PEG400 MPD
Table 2.2: Crystallization conditions for the plasmodial and T. thermophilus structures.
2.5.2 Crystallographic data processing
Fundamentals of data processing
Indexing. The indexing procedure consists of assigning the unit cell parameters
a, b and c and corresponding angles α, β and γ based on the symmetry of
the diffracted reflections. The software reads the spot positions from one or
more diffraction images, considering the crystal distance to detector. The spot
position provides information about the crystal lattice, that can enclose several
posibilities. The task is to find the lattice vectors with the highest Bravais
lattice symmetry and lowest penalty. Once the lattice symmetry is chosen,
parameter refinement (unit cell parameters, crystal orientation, the crystal-to-
detector distance and position) is constrained to the chosen lattice symmetry.
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Integration and scaling. After the unit-cell parameters and orientation are
known, integration of the spots can be performed. During integration, all raw
pixel intensity of full reflections, as well as partial reflections spread over mul-
tiple images are converted into single reflections by considering a defined pixel
area (peak/background area) of the reflections. The proccess consists of esti-
mating the intensities of the reflected spots and error value to each intensity
by substracting the x-ray background. The background is measured in a region
around the reflection. At the end all values for the intensities are listed in the
form of Miller indices hkl with respective intensities I (hkl) and estimated errors
σI (hkl) for each observed reflection.
Many measured reflections from identical reflections or symmetry-related reflec-
tions are further scaled and merged in a process called data reduction, in order
to generate unique reflections dataset that corresponds to the asymmetric unit
of the reciprocal space. The indicators of data quality will be reflected in the
Rmerge (equation 2.4), redundancy and the signal-to-noise ratio (I/σI) in each
shell and in the entire dataset. The statistical values for each dataset processed
in this work are shown in Tables 3.7 and 3.9.
Rmerge =
∑
h
∑N
i=1 |I(h)i − I¯(h)|∑
h
∑N
i=1 I(h)i
(2.4)
where N is the number of redundant observations of a given reflection h and
I¯(h) is the average intensity of each reflection.
Datasets collected from PbPdx1and PbPdx1-R5P crystals were indexed in R32
and for PbPdx1/Pf Pdx2H196N crystals in P6122 space groups. The indexed
data were reduced using Denzo and Scalepack from HKL 2000 software [39].
Datasets from TtPdx1 crystals were indexed in the R32 space group and inte-
grated with iMOSFLM [38]; scaling was performed using Scala [40]. Details of
data processing from all structures are listed in Tables 3.7 and 3.9.
2.5.3 Structure solution and refinement
Fundamentals of structure determination and refinement
Three methods exist to calculate experimental phases:
• Molecular Replacement
• Multiple Isomorphous Replacement
• Multiple Anomalous Dispertion
3-Dimensional structure models were available to permit the use of the molecular
replacement method to solve the structures of this study.
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Molecular Replacement
The phases are obtained using the coordinates of a model with sufficient ho-
mology to the structure to be solved. To calculate the amplitudes Fcalc and
the phases Φcalc, the coordinates of the solved model are positioned in the unit
cell by rotation and translation functions. With the help of the Patterson map,
intramolecular vectors - which depend on the orientation of the molecule - are
used in the rotation function. The Patterson map of the unknown structure is
compared to the Patterson maps of the known structure in different orienta-
tions. The correlation between the two maps is obtained when the two vectors
have similar orientation. Subsequently, when the orientation of the molecule is
known the translation function - based on the intermolecular vectors - places
the molecule to the correct coordinates in the assymetric unit. The phases de-
rived from the model and the experimental observed amplitudes Fobs are used
to calculate an electron density map. The model is further built manually and
refined to find the differences between the model and the target and establish
an agreement to the experimental data.
In this study, the structures of PbPdx1 and PbPdx1-R5P at 2.4 A˚ resolu-
tion were solved by molecular replacement using MOLREP from CCP4 suite
[41]. BsPdx1 (PDB entry 2NV1, [14]) was used as starting model for the
PbPdx1 structure. Iterative model building of the chains in the asymmetric
unit and refinement were carried out with Coot [42] and REFMAC5 [43].
Water molecules were added to the model using ARP/wARP . The chimera
PbPdx1/Pf Pdx2H196N structure was solved by molecular replacement using
Phaser [44] with the refined PbPdx1 as a search model. The 6 Pf Pdx2H196N
subunits were found one by one, using the solution obtained from Phaser in
MOLREP as fixed input model and Pf Pdx2 (PDB entry 2abw, [24]) as a
search model. All obtained models were refined in REFMAC5 (Table 3.6).
The TtPdx1 structures were solved by molecular replacement using imosflm
[38] and phases from TtPdx1 (PDB entry 2ZBT).
Structure refinement. Considerations of refinement at low resolution
After a macromolecular structure model is obtained from molecular replace-
ment, the model can be refined. Refinement consists of minimizing errors in the
geometry and stereochemistry of bond lengths and angles, which remain after
real space model building [45]. The parameters of a model are refined against
the experimental data to obtain the best fit between the structure factor ampli-
tudes of the observed Fobs and calculated Fcalc model, quantified by the Rwork
(Equation 2.5):
Rfactor =
∑
h |Fobs − Fcalc|∑
h Fobs
(2.5)
A cross-validation against a subset of unused experimental data (5% of the
22
data) is monitored by the Rfree value, which has the same equation as the
Rwork (Equation 2.5).
Crystals that diffract to high resolution produce interpretable electron density
maps because the diffraction data contains information of atomic distances d
< 2.5 A˚ (e.g. PbPdx1, TtPdx1 and their corresponding derivatives solved in
this work). For low-resolution crystal structures (e.g. PbPdx1/Pf Pdx2H196N
structure), side chains cannot be easily placed. The problem stems from the lack
of sufficient number of observations contained in the diffraction data required
to define the position of atoms at high resolution. The availability of high
resolution structures as molecular replacement models (i.e., PbPdx1 at 2.4 A˚
resolution and Pf Pdx2 at 1.6 A˚ resolution [24]) served as useful starting point
for the refinement at low resolution (i.e. PbPdx1/Pf Pdx2H196N structure). Cα
fragments are traced of regions such as, loops and α-helices not possible to
visualize in places where they are disordered in the individual subunits. The
regions can be modelled manually in the electron density maps with programs
like Coot and then refined using non-crystallographic symmetry (if symmetry
related molecules are present in the assymetric unit), rigid body refinement
and/or secondary structure restraint using algoritms available in Phenix and/or
CCP4i suites to improve experimental phases. Details of refinement statistics
from all structures are listed in Tables 3.7 and 3.9.
2.5.4 Structure analysis
Structural superposition
Differences between PbPdx1/Pf Pdx2H196N and BsPdx1/BsPdx2H170N
complexes were seen by superposition of the Cα backbone of a single Pdx1 from
the two structures, using the lsqkab program from the CCP4 suite [41]. The
program calculated the root main square deviation of the Cα atoms (rmsd). The
resulting coordinates were recorded and used to superpose individual Pdx2 chain
from PbPdx1/Pf Pdx2H196N onto a single Pdx2 from PbPdx1/Pf Pdx2H196N in
lsqkab, providing both the rotation matrix and translation distance between
centroids. The rotation matrix was used to calculate the rotation angle.
Electrostatic surface analysis
Comparison of the electrostatic surfaces between PbPdx1 (solved in this study)
and Pf Pdx1 from the Pf Pdx1/Pf Pdx2 model described by [15] were done
by superposition of the two structures in Pymol and further calculation of
the electrostatic map using Adaptive Poisson-Boltzmann Solvent (APBS) tool
www.umich.edu/~mlerner/Pymol.
Ligand-protein building and representation
The R5P and PLP coordinates were sketched with the CCP4 library sketcher
[41]. The monomer library files were used as input coordinates for manual
building in Coot of the R5P in the active site of PbPdx1 and TtPdx1, as well
as PLP in TtPdx1 and further refinement in Refmac5. Schematic diagrams of
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ligand-protein interaction were generated with the program ligplot [46].
2.5.5 Electron microscopy analysis
Protein samples of PbPdx1 in complex with PbPdx2 or PbPdx2H199N , as well as
Pf Pdx1 and Pf Pdx1/Pf Pdx2H196N complex were prepared in reaction buffer
used for enzymatic assays (§ 2.3), containing 50 mM Tris pH 8.0, 20 mM NaCl
and -/+ 10 mM Gln. The samples in a concentration of 20 µg/ml were stained
with 2 % uranyl acetate and placed onto a carbon-coated grid using the sandwich
technique as detailed in [47]. The data were recorded either with a CM120
Biotwin electron microscope at 100 kV and a nominal magnification of 53,000x
on a 4kx4k Tietz-CCD-camera or with a FEI F20 electron microscope at 200
kV with a nominal magnification of 29,000x on a Tietz 8kx8k CMOS camera.
The nominal pixel size was 2.36 A˚/pixel for the CM120 and 2.8 A˚/pixel for the
F20, respectively. For image analysis, particle images were semi-automatically
selected with the autobox option of Boxer [48]. Subsequent alignment and
classification were done with IMAGIC 5 [49].
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Chapter 3
Results
3.1 Assembly of the PLP synthase complex in
Plasmodium
3.1.1 Crystallization of the plasmodial PLP synthase com-
plex
Structural studies in the bacterial Pdx1/Pdx2 complex have shown that several
conformational changes occur in the two subunits upon complex formation [14,
16]. Some of these are implicated in mediating the protein-protein interface
e.g., the αN terminus of Pdx1 and structural changes leading to a peptide flip
in Pdx2 (described in § 1.2.1).
To understand what promotes a stronger protein-protein interaction in the plas-
modial Pdx1/Pdx2 when compared to the bacterial complex, a structural model
was built based on the known bacterial complex and P. falciparum Pdx2 struc-
tures. This model proposed possible regions required at the interface not present
in the bacterial complex and explained the variations seen in the protein se-
quence between the bacterial Pdx1 and plasmodial Pf Pdx1 (54% identical),
Alignment D.1. However, a true structure was necessary to characterize these
differences in more detail.
Several crystallization attempts were pursued with the P. falciparum PLP syn-
thase complex and failed. Instead, proteins from the rodent malaria parasite P.
berghei were succesfully crystallized, obtaining different forms: needle-, star-,
rombohedral- and spear- crystals. Crystallization was carried out using purified
PbPdx1 and PbPdx2 or PbPdx2H199N proteins in the presence and absence of
L-glutamine. Crystals were obtained from different preparations:
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• PbPdx1 and PbPdx2H199N were mixed 1:1 ratio and gel filtered before
crystallization (Figure 3.1, upper panel)
• the mixed proteins were subjected to crystallization in the presence of
glutamine (Figure 3.1, lower panel a, c and d ) and,
• a protein mixture containing PbPdx1/PbPdx2 was crystallized in the ab-
sence of glutamine (Figure 3.1, lower panel b).
All crystal forms were tested by x-ray crystallography, giving weak and aniso-
tropic diffraction at low resolution (≥ 4.5 A˚). The highest resolution was ob-
tained by the needle crystals grown from a mixture of PbPdx1/PbPdx2H199N
gel filtered previous to crystallization (Figure 3.1, upper panel). Several crys-
tallization conditions such as, temperature, purification buffer and protein ratio
variations were tried, in order to improve diffraction resolution, but were un-
successful and structure solution was not pursued.
Due to the crystallization problems encountered with the Pdx1/Pdx2 complexes
from P. berghei described above, a chimera consisting of Pdx1 from P. berghei
and Pdx2H196N from P. falciparum was subjected to crystallization. The syn-
thase and glutaminase from the different parasites formed a complex in vitro,
as seen in size exclusion chromatography (Figure 3.2). The two Pdx1 and Pdx2
proteins from the human and rodent parasites share high similarities in protein
sequence, 84.5% between Pf Pdx1 and PbPdx1 and 63.8% between Pf Pdx2 and
PbPdx2. The chimera PbPdx1/ PbPdx2H199N complex succesfully crystallized
(Figure 3.2, top right) and diffracted to 3.6 A˚ resolution.
3.1.2 Reciprocal activation and interaction of Pdx1 and
Pdx2 from different plasmodial species
Earlier studies described the importance of helix αN of Pdx1 for heteromeric
Pdx1/Pdx2 interaction and glutaminase activation [14, 15]. Furthermore, the
role of αN showed species specific properties, when analysing the interaction of
a Pf Pdx1 “swap mutant” containing the αN helix from BsPdx1 by isothermal
titration calorimetry [15]. The mutant interacted and activated the BsPdx2
glutaminase subunit but not Pf Pdx2. Additionally, in vivo complementation
and in vitro studies showed PLP synthesis is depleted when the parasite Pdx1
and bacterial Pdx2 interaction is induced [24], suggesting there are species-
specific features for the PLP synthase complex activation.
To test whether the P. falciparum and P. berghei Pdx1/Pdx2 complexes share
similar activation properties that would allow to validate the chimeric PbPdx1/
Pf Pdx2H196N complex as an apropiate system to study the plasmodial PLP
synthase complex, enzymatic and thermodynamic experiments by ITC were
carried out with the genuine complexes and the two possible chimeras P. berghei
Pdx1 with P. falciparum Pdx2 and viceversa.
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Figure 3.1: Purification and crystallization of the P. berghei Pdx1/Pdx2 complex.
Upper panel, purified PbPdx1 and PbPdx2H199N proteins were mixed 1:1 ratio to a final
concentration of 0.5 mM and loaded onto a Superose 6 10/300 GL (GE Healthcare). The
elution profile is shown and collected fractions from corresponding A, B, C and D peaks
were evaluated by SDS-PAGE (middle). The apparent molecular weight of peak A is
817 kDa, for the 24 mer of Pdx1/Pdx2 (theoretical value 708 kDa) calculated with the
calibration curve (lower, right). Needle crystals (upper, right) from the pooled peak A
fractions appeared under the condition containing 0.1 M Hepes pH 6.0, 0.2 M NaNO3,
1.9 M NH2SO4. The needle crystals diffracted anisotropically to 4.5-5.5 A˚ resolution.
Lower panel, the purified PbPdx1 and PbPdx2 or PbPdx2H199N were mixed 1:1 ratio
to a final concentration of 0.5 - 1 mM in the absence and presence of 10 mM glutamine
and crystallized under the conditions: a, 0.1 MES pH 6.0, 5% PEG6000; b, 0.1 Hepes pH
7.0, 5% PEG6000; c, 0.1 M Bicine pH 9.0, 2 M NaCl, 10% PEG6000; and d, 0.1 M Tris
pH 8.0, 1 M LiCl, 10 % PEG6000. Crystals obtained in a, c and d, contained variant
PbPdx2H199N in the presence of glutamine and, crystals obtained under the condition
b, contained Pdx2 in the absence of glutamine. All four crystal forms diffracted to poor
resolutions lower than 8 A˚ resolution.
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Figure 3.2: Purification and crystallization of the chimeric PbPdx1/PfPdx2H196N
complex in the presence of glutamine. Purified PbPdx1 and PfPdx2H196N were mixed
1:1 molar ratio to a final concentration of ∼ 1 mM in the presence of 10 mM glutamine
and loaded onto a gel filtration column Superose 6 10/300 GL (elution profile is shown).
Samples from peak fractions A, B and C were evaluated by SDS-PAGE (middle). Elution
peak B corresponded to the PbPdx1/PfPdx2H196N complex with a molecular mass of
610 kDa, calculated using the calibration curve shown in Figure 3.1. The sample from
fraction peak was concentrated to 15 mgml and used for crystallization. Crystals of the
PbPdx1/PfPdx2H196N complex with ∼ 20 µm appeared under 0.1 M Na/K Phosphate
pH 6.2, 0.2 M NaCl, 10% NaCl at 19◦C (right).
Activation of Pdx1 and Pdx2 from P. falciparum and P. berghei
PLP synthesis and glutaminase activity were monitored under saturating condi-
tions of substrates, as described in § 2.3. The PbPdx1/Pf Pdx2 complex showed
an overall PLP and glutaminase activities similar to the genuine complexes
PbPdx1/PbPdx2 and Pf Pdx1/Pf Pdx2, respectively (Table 3.1). The control
Pf Pdx1/PbPdx2 complex had a PLP activity similar to Pf Pdx1/Pf Pdx2. Glu-
tamine hydrolysis showed a slight dependency of the subunit origin, for exam-
ple, the chimera containing P. falciparum Pdx2 had a slight increase of gluta-
minase activity, whereas the chimera containing PbPdx2 was decreased like the
PbPdx1/PbPdx2, each with activities similar to the genuine complexes (Table
3.1). The results suggest that variations in the Pdx2 activity are independent
on the plasmodial Pdx1 subunit used.
Interaction between Pdx1 and Pdx2 subunits from P. falciparum and
P. berghei
The Pdx2 substrate L-glutamine was reported to play a major role in strength-
ening the Pdx1 / Pdx2 interaction, leading to 23-fold increased affinity of the B.
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PLP synthesis Glutaminase activity
PfPdx1/PfPdx2 0.7 ± 0.1 260 ± 28
PbPdx1/PbPdx2 1.1 ± 0.2 150 ± 12
PbPdx1/PfPdx2 1.3 ± 0.1 233 ± 14
PfPdx1/PbPdx2 0.9 ± 0.1 175 ± 20
Table 3.1: PLP synthesis and glutaminase activities of P. falciparum and P. berghei
complexes (in nmol/min.mg)
subtilis and to 29-fold increased affinity of the P.falciparum proteins [15, 33]. To
test the influence of L-Gln on complex formation, the chimera PbPdx1/Pf Pdx2
and controls PbPdx1/PbPdx2 or Pf Pdx1/PbPdx2 complexes were analysed by
ITC as described in § 2.4.1. Pdx2 (or catalytically inactive Pdx2: PbPdx2H199N
and Pf Pdx2H196N ) was used as the titrant in the presence or absence of 1 mM
glutamine at 25◦C. The titration data for all analysed complexes are shown in
Figure 3.3. In contrast to P. falciparum PLP synthase complex [15], addition of
L-glutamine to P. berghei proteins did not show significant increase in affinity
as judged from the similar dissociation konstant (Kd) values in the presence and
absence of glutamine (Table 3.2). Chimeric complexes behaved like complexes
from P. berghei and showed no (PbPdx2 vs. Pf Pdx1) or little (Pf Pdx2 vs.
PbPdx1) dependence on addition of L-glutamine, according to the Kd values
(Table 3.2). The ITC data suggest that in all cases the proteins become more
ordered when substrate glutamine binds as entropy loss occurs and additional
interactions are formed, seen as enthalpy gain.
N Kd ∆G ∆H -T∆S
(nM) (kJ/mol) (kJ/mol) (kJ/mol)
PfPdx1/PfPdx2 1±0.1 2000±300 -33±1 12±3 -44±3
PfPdx1/PfPdx2/Gln 0.9±0.1 70±40 -41±1 -34±6 -6±6
PbPdx1/PbPdx2 0.84±0.1 83.1±30.4 -41.1±0.9 -16.0±1.1 -25.2±1.1
PbPdx1/PbPdx2/Gln 0.8±0.12 45.9±17.6 -42.5±1.3 -52.7±11.5 10.2±10.5
PbPdx1/PfPdx2 1.1±0.07 90.9±9.0 -40.2±0.3 9.8±1.1 -50.0±1.3
PbPdx1/PfPdx2/Gln 0.9±0.13 36.3±9.9 -42.6±0.7 -42.8±2.2 -0.2±1.6
PfPdx1/PbPdx2 0.6 143 -39 -25 -14
PfPdx1/PbPdx2/Gln 0.8 130 -39 -58 -19
Table 3.2: Interaction of Pdx1 and Pdx2 from P.falciparum and P. berghei in absence
and presence of glutamine
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Figure 3.3: Isothermal titration calorimetry of the plasmodial PLP synthase complexes
in absence or presence of 1 mM L-glutamine. Upper pannel shows the ITC results of the
PbPdx1/PbPdx2, PbPdx1/PfPdx2 and PfPdx1/PbPdx2. In the lower panel, the ITC
results of the same complexes in the presence of glutamine are shown, using inactive
Pdx2 with a mutation at the His residue for Asn (PbPdx2H199N and PfPdx2H196N ).
Binding assays and fitting of the heat signals were performed as described in § 2.4.1.
3.1.3 Reciprocal interaction of Pdx1 and Pdx2 for enzyme
activation
Effect of Pdx1 in glutamine binding by Pdx2
Activation of Pdx2 requires the presence of Pdx1 [50]. Basal glutamine hydro-
lysis is observed in the absence of Pdx1 and is enhanced in the presence of the
PLP synthase (Table 3.3). To test whether Pdx2 can bind glutamine before
complex formation with Pdx1, ITC measurements were done at 25◦C. When
glutamine was titrated into PbPdx1 or PbPdx2H199N , no heat was observed,
while titration into a mixture of 1:1 molar ratio of PbPdx1/PbPdx2H199N did
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produce heat of binding generated by the substrate (Figure 3.4). This suggests
that the substrate glutamine does not bind tightly to the autonomous Pdx2
subunit, and instead requires a preformed Pdx1/Pdx2 complex.
Glutaminase activity
PbPdx2 24 ± 6
PbPdx1/PbPdx2 150 ± 12
Table 3.3: Glutaminase activity of P. berghei Pdx2 influenced by Pdx1 in nmol/min.mg
Figure 3.4: Isothermal titration calorimetry of glutamine into the plasmodial PLP
synthase complex. Titration of 100 mM glutamine into 40 µM PbPdx1 (left), 40 µM
PbPdx2H199N (middle) or 40 µM PbPdx1/PbPdx2H199N (right). No significant heat
change is observed after titration of glutamine into the autonomous Pdx1 and Pdx2
proteins.
Effect of R5P in Pdx1/Pdx2 interaction and glutaminase activation
A particular feature of glutamine amidotransferases is an acceptor domain for
ammonia. Usually, it is expected that this ammonia acceptor promotes the
activation of the glutaminase. In contrast, the glutaminase rate in the PLP
synthase complex is not influenced by an ammonia acceptor [12]. Whether the
substrate R5P is required to enhance protein complex assembly is not known.
To discard the possibility Pdx1 had bound R5P from the bacterial cytosol during
protein expression, the purified Pdx1 was incubated with 1 mM G3P and 10 mM
NH4Cl at room temperature, followed by dialysis and gel filtration to remove
remnants of substrates and PLP. The protein free of R5P adduct was used
in the enzymatic and interaction assays. The activity of Pdx2 was tested in
the presence or absence of R5P and was similar in both assays (Table 3.4). In
addition, unbound Pdx1 was used for interaction studies by ITC (Table 3.5) and
analytical ultracentrifugation (AUC) (Figure 3.5). The results showed Pdx1 and
Pdx2 can interact in the same manner independent on the presence and absence
of the sugar.
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Glutaminase activity
PbPdx1/PbPdx2 183 ± 39
PbPdx1/PbPdx2/R5P 179 ± 14
Table 3.4: Glutaminase specific activity of P. berghei PLP synthase complex in the
presence or absence of R5P (in nmol/min.mg)
N Kd ∆G ∆H -T∆S
(nM) (kJ/mol) (kJ/mol) (kJ/mol)
PbPdx1/PbPdx2 0.84±0.1 83.1±30.4 -41.1±0.9 -16.0±1.1 -25.2±1.1
PbPdx1/PbPdx2/R5P 1 99.0±25 -40±0.6 -14.2±2 -26±0.4
PbPdx1/PbPdx2/R5P/Gln 0.94±0.02 85±28 -40.4± -49± -8.2±10.5
Table 3.5: Effect of R5P on the interaction of Pdx1 and Pdx2 from P. berghei analysed
by isothermal titration calorimetry.
ρa (g/cm3) ηb (cP) Sexp
c (S) Mexp
d (kDa) Mcalc
e (kDa)
PbPdx1/PbPdx2 0.9 0.001 19.3 611 720.12
2.5 28.02 26.5f
PbPdx1/PbPdx2/R5P 1 0.001 19.4 590.4 721.872
2.53 27.7 26.5f
PbPdx1/PbPdx2/R5P/Gln 1 0.001 19.2 582 724.536
2.5 27.26 26.5f
Figure 3.5: Analysis of the R5P effect in the PbPdx1/PbPdx2H199N complex in the
presence of L-Gln by AUC. Sedimentation velocity runs at 35000 rpm at λ=280 nm.
Sample concentration was with an absorbance of 1 at 280 nm. The frictional ratio for
all Pdx1/Pdx2 complexes were 1.3.
a and b, buffer density and viscosity, respectively calculated using SEDNTERP version
1.09 (University of New Hampshire).
c, sedimentation coefficients calculated from the c(s) distribution of the raw data pro-
cessed in Sedfit [35].
d, molecular weight derived from molar mass distribution using Sedfit.
e, molecular weights calculated from aminoacid sequence with and without substrate(s).
f , corresponds to the molecular weight of PbPdx2 calculated from the protein sequence.
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3.1.4 Pdx2 occupies the Pdx1 dodecamer randomly
Since crystallization attempts of the Pf Pdx1/Pf Pdx2 or Pf Pdx1/Pf Pdx2H196N
complexes in the presence and absence of glutamine did not give any crystal hits,
electron microscopy (EM) studies 1 were caried out in the presence of glutamine
and catalytic inactive Pf Pdx2H196N . Unexpectedly, the Pf Pdx1/Pf Pdx2/L-
Gln complex formed high order of fiber-like aggregates constituted by stacked
heteromeric 24mer Pdx1/Pdx2 complexes, as shown by the densities in the
class averages (see Figure 3.6, a). The protein aggregation was dependent on
Pf Pdx1, since the protein alone also formed fibers (Figure 3.6, b). Interestingly,
the high molecular aggregates of Pf Pdx1 were not seen in size exclusion chroma-
tography. To discard the possibility that modified His-tag proteins would form
aggregates, native proteins were also analysed. However, the untagged Pf Pdx1
formed fibers. During the protein purification Pdx1 eluted under different salt
concentrations, i.e., different ionic species were present, as shown in the ionic
exchange purification profile (Figure 3.7) and each fraction peak showed the
same elution profile after gel filtration (Figure 3.8, example for one purification
profile). Neither of these protein samples were crystallizable. The electrostatic
surface at the interface of opposite Pdx1 subunits using the Pf Pdx1/Pf Pdx2
model [15] and PbPdx1 did not show differences in the contact of the two Pdx1
proteins (Figure 3.9), difficult to discern the cause of fiber formation in the P.
falciparum PLP synthase.
Figure 3.6: Fiber formation in the PfPdx1/PfPdx2 complex shown by EM. Purified
native PfPdx1 and PfPdx2H196N proteins were mixed 1:1 ratio and analysed in the
presence of 10 mM glutamine by EM. In a) PfPdx1/PfPdx2H196N in the presence of
glutamine; b) PfPdx1 protein. Protein preparation for the EM contained 20 µg/ml. The
arrows show fiber-like aggregations of the proteins.
When analysing the B. subtilis Pdx1/Pdx2 complex, it was noticed that the
complex requires the catalytically inactive Pdx2 variant in the His residue of
the catalytic triad to stabilize the Pdx1/Pdx2 interaction [14]. Due to fiber
formation with the P. falciparum Pdx1 and Pdx2 proteins and poor diffraction
encountered with the P. berghei Pdx1/Pdx2 crystals, the P. berghei proteins
1EM class averages and pictures shown in this study were made by Dr. Katharina Hipp,
formerly European Molecular Laboratories (EMBL), now at the University of Edinburgh, UK
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Figure 3.7: Elution profile of native PfPdx1 by AEC using a Source 30Q matrix.
PfPdx1 eluted with a NaCl gradient from 10 to 800 mM at different concentrations:
28.2 (peak A), 221 (peak B), 408 (peak C) and 499 (peak E). The green line represents
the gradient elution. Each peak fraction was pooled and loaded onto Superdex S200
26/60. An example of the purification by size exclusion chromatography is shown in 3.8.
Figure 3.8: Elution profile and purification of PfPdx1. Elution profile of PfPdx1
from a Superdex S200 26/60 column shows two elution peaks A and B at 121 and
138 ml with molecular mass of 707 and 435 KDa, respectively, calculated using the
calibration curve shown in Figure B.1. Theoretical value of one PfPdx1 subunit is 33.013
KDa (accession code C6KT50 http://www.uniprot.org/) and for 12 Pdx1 subunits,
396.01 kDa. Evaluation of the fraction peaks by SDS-PAGE is shown (right). Peak B
corresponds to the elution of PfPdx1 dodecamer.
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Figure 3.9: Electrostatic surface analysis of PfPdx1 and PbPdx1. A) Two oppo-
site monomers, 1 and 2, of PbPdx1 (left), indicating the interface with a rectangle.
Monomer2 is rotated 90◦ to show the electrostatic surface of the two monomers inter-
face (right). Surface regions of structural elements such as, αN, C-terminus (C-term)
and α8” as well as, position of the active site are labelled. B) Two opposite monomers
of PfPdx1 from the PfPdx1/PfPdx2 described in [15] are shown as in A). The electro-
static surface of additional segments (βN and α2’) not visible in PbPdx1 are labelled.
The electrostatic surface was generated with the APBS tool in Pymol, as described in
§ 2.5.4. Blue and red patches correspond to positively and negatively charged residues,
respectively. The molecular surface was setted to -25 to 25 to visualize the electrostatic
map.
were analysed by electron microscopy to see whether these homologue proteins
formed fibers as the P. falciparum proteins. For the assay, active and inactive
Pdx2 were used. The PbPdx1 and PbPdx2 proteins were mixed in equimolar
concentrations and visualized by electron microscopy. Unexpectedly, few Pdx2
subunits of the active protein ocuppied the Pdx1 ring, even in the presence of
glutamine (Figure 3.10, a). The control experiment, consisting of PbPdx1 and
inactive PbPdx2H199N showed Pdx1 dodecameric particles fully occupied with
Pdx2 in the presence of glutamine (Figure 3.10, b), as observed by size exclusion
chromatography analysis (Figure 3.1).
The fiber formation observed with Pf Pdx1 and Pf Pdx1/Pf Pdx2 not seen when
using the P. berghei homologue proteins might be a time and concentration-
dependent process and would explain why autonomous Pf Pdx1 or in complex
with Pf Pdx2 complex failed to crystallize. The results also showed Pdx1/Pdx2
complexes require the inactive Pdx2 to stabilize the heterodimers, as seen in the
bacterial complexes because clearly a different pattern distribution is possible
to see when active Pdx2 is used, in which Pdx2 attaches to Pdx1 complexes
randomly.
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Figure 3.10: EM analysis of the PbPdx1 / PbPdx2 complex in the presence of glu-
tamine: (a) EM image taken from a PbPdx1/PbPdx2 sample. The scale bar represents
100 nm. The class average (3.098 particles: four out of 100 classes) shows Pdx1 dode-
cameric core particles differentially occupied with Pdx2. Full occupancy of the Pdx1
dodecamer with Pdx2 is not observed, indicated with black arrows. The scale bar on the
class averages represents 10 nm; (b) class average of the P. berghei PLP synthase complex
with the PbPdx2H199N variant, showing higher occupancy of Pdx1 with PbPdx2H199N .
3.2 The plasmodial Pdx1/Pdx2 structure
Initial attempts to determine the PbPdx1/Pf Pdx2H196N structure by molecular
replacement (MR) failed when using BsPdx1/BsPdx2 (PBD code 2NV2, [14])
as a template in the form of hetero-dodecamers (6 Pdx1 and 6 Pdx2 subunits)
or heterodimers of Pdx1/Pdx2. The experimental phases were then obtained by
consecutive MR, using high resolution structures from P. berghei Pdx1 at 2.4
A˚ (determined in this work, Table 3.7) and P. falciparum Pdx2 at 1.6 A˚ (PBD
code 2AWB, [24]) as search models. Initially, the Pdx1 hexamer was searched
by MR, giving a refinable solution. The packing of the hexamer in the unit cell
showed clear space for the placement of Pdx2 subunits. On this MR solution, 6
subunits of Pf Pdx2 (PDB 2ABW) structure were added by their superposition
onto the bacterial complex as a reference. Using this model in MR also failed,
suggesting from this result and the previous MR attempt with the bacterial
dimer or hetero-dodecamer that Pdx2 position in the plasmodial complex differs
from the bacterial system. Therefore, MR was performed fixing the Pdx1 model
as input coordinates and searching for Pdx2. The Pdx2 subunits were found
consecutively and refined as rigid bodies after every MR solution (Table 3.6).
The last Pdx2 subunit (chain 6) found in the asymmetric unit after MR had low
occupancy, due to the absence of crystal contact and is reflected by the slightly
change of the figure of merit (FOM) and Rfactors shown in Table 3.6. A final
model containing 6 Pdx1 and 6 Pdx2 subunits in the asymetric unit and 59 %
solvent content was refined at 3.6 A˚ resolution (Table 3.7).
The overall architecture of the complex resembles the complexes described from
T. maritima [13] and B. subtilis [14]. It consists of 12 Pdx1 subunits forming
a dodecamer of two hexameric rings occupied by 12 Pdx2 subunits interacting
with each Pdx1 (Figure 3.11). Differences on Pdx1 and Pdx2 are seen when
the bacterial and plasmodial complexes are superposed, with an rmsd of 0.931
A˚ calculated over the main chain of 261 residues out of 297, belonging to the
(β/α)8 core of one Pdx1 subunit in the two structures and excluding the residues
at the N and C-terminal regions. Superposition of the Pdx1 subunits showed
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P6122 Pdx2 Rwork Rfree FOM
6 Pdx1 - 41.8 42.2 0.61
1 41.8 41.3 0.61
2 40.8 40.2 0.64
4 38.0 38.2 0.68
5 36.8 37.0 0.69
6 37.2 37.7 0.68
Table 3.6: Molecular replacement and refinement statistics of the
PbPdx1/PfPdx2H196N structure. Molecular replacement was performed as de-
scribed in § 2.5.3. Models containing 6 Pdx1 (P6122) with 1, 2, 4, 5 or 6 Pdx2 subunits
were refined with each Pdx1 and Pdx2 domains as rigid bodies, using Refmac5 from
CCP4i [41]. Rwork and Rfree are defined in equation 2.5. Figure of merit (FOM)
represents the phase probability distribution, tending to 1 when the phase angles are
well defined and to 0 when the error of the measured phase angles increases. Highlighted
values correspond to the final model consisting of 6Pdx1 and 6Pdx2.
ga48-3 ga50-3 ga38-5
PbPdx1 PbPdx1-R5P PbPdx1/
PfPdx2H196N
Space group R32 R32 P6122
Unit cell a, b, c (A˚) 180, 180, 102 181, 181, 102 160, 160, 583
α, β, γ (◦) 90, 90, 120 90, 90, 120 90, 90, 120
Solvent content (%) 49 54 54
# of mol in AU 2 2 12
Resolution (A˚) 50 - 2.42 62.2 - 2.4 138.6 - 3.6
Unique reflections 23093 23988 77437
Rmerge (%) 3.6 - 44.7 4.2 - 44 10.6 - 37.6
Completeness (%) 100 - 98.5 99.9 - 99.38 96 - 93.7
I/σI 48.7 - 3.2 9 - 2.3 10 - 2
Redundancy 6.7 6.1 5.1
Refinement
Rfree (%) 23.2 28 29
Rwork (%) 18.5 21 28
# of amino acids 539 555 2988
# of Water 107 68 3
# ligands 2 4 12
# of protein atoms 4189 4168 23094
Ligand/ion atoms 20a 26b 60c
Ramachandran most favored (%) 93.2 92.1 68.5
Ramachandran additional allowed (%) 6.6 6.8 20.3
Ramachandran generously allowed (%) 0.2 0.8 6
Ramachandran disallowed (%) 0 0.2 5.2
RMSD bonds (A˚) 0.022 0.0168 0.016
RMSD angles (◦) 1.984 1.8482 1.668
Table 3.7: Crystallographic analysis of the plasmodial structures. Rmerge, Rwork and
Rfree are defined in equations 2.4 and 2.5. Rfree was calculated by excluding 5% of the
experimental data.
a and c values were calculated for phosphate ions; b values were calculated for ribose
5-phosphate
Pdx2 backbone is displaced 1.6 A˚ and rotated 8.5◦ with respect to Pdx1 (Figure
3.12, left).
Analysis of the electron density maps of PbPdx1/Pf Pdx2H196N structure showed
regions not resolved in the electron density of autonomous proteins, difficult for
the intrepretation of amino acid side chain position at 3.6 A˚ resolution. However,
backbone of the main chain of secondary structure regions such as, loops and
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α-helices not visible in the autonomous subunits were possible to trace and
build manually in the electron density map, using the high resolution structures
BsPdx1/BsPdx2, P. berghei Pdx1 and P. falciparum Pdx2 as references. The
use of non-crystallographic symmetry in Coot and rigid body refinement with
multiple rigid bodies (each chain considered as a rigid body) in Phenix [51]
were used to improve experimental phases.
Figure 3.11: Structure of the plasmodial PLP synthase complex. Pdx1 forms a
dodecamer-like structure with 12 Pdx1 subunits (blue). Pdx2 (brown) attaches to each
Pdx1 subunit. One Pdx1/Pdx2 heterodimer is highlighted (right side). Top and side
views are shown by rotating the complex by 90◦.
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3.2.1 Plasmodial Pdx1/Pdx2 interface: structural changes
induced by complex formation
Helix αN of Pdx1 required for complex formation and glutaminase activation
[14, 15] is partially ordered and becomes stabilized once Pdx1 interacts with
Pdx2. An earlier model of the PLP synthase from P. falciparum proposed that
helix αN would be preceeded by a small beta strand (named βN) that orients
to the Pdx2 subunit and runs parallel to the β7 of the central beta sheet of
this protein, as shown in T. maritima and B. subtilis [13, 14]. Interestingly,
the very N-terminus in the chimeric complex differed in this important region
and was not oriented towards Pdx2, instead is oriented to Pdx1 (Figure 3.12,
right), suggesting the very N-terminus can acquire a different conformation in
eukaryotic PLP synthase complexes.
Figure 3.12: Comparison between bacterial and plasmodial Pdx1/Pdx2 heterodimers.
Superposition of Pdx1 from Plasmodium (blue) onto Pdx1 from B. subtilis (green) re-
veals the displacement and rotation of the plasmodial Pdx2 subunit (brown) 1.6 A˚ and
8.5◦, respectively, with respect to bacterial Pdx2 (pink). Helix α2’ of Pdx1 is seen also
in a different position. Pdx1/Pdx2 interface is zoomed in to show the position of the
N-terminus and loops 95-111 and 124-127 of the plasmodial heterodimer.
A particular loop that connects β5 and β6 in Pdx2 (residues 95-111) is extended
by additional seven residues not observed in the bacterial homologues, and forms
a helical turn α5-1 (Figures 3.13). This segment contacts the loop α2-β3 in Pdx1
(Figure 3.12, right), a conserved region in P. falciparum Pdx1.
Pdx1/Pdx2 complex formation induces additional changes in the interface. Two
loops in Pdx2 important for glutaminase activation [16], i) loop Q12 connecting
α1 and β1 and ii) oxyanion hole loop (Figure 3.13), acquire a similar confor-
mation as seen in the bacterial Pdx2 complexed to Pdx1. In addition, a loop
β6-β7 (amino acid residues 124-127) not resolved in electron density of the 1.6
A˚ Pdx2 structure alone is visible in the chimeric complex (Figure 3.13), and is
located at the interface region with Pdx1 (Figure 3.12, right).
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Figure 3.13: Comparison between bacterial and plasmodial Pdx2 Structures. Superpo-
sition of autonomous PfPdx2 (yellow, PDB 2ABW) and BsPdx2 from the Pdx1/Pdx2
complex (pink, PBD 2NV2) onto PbPdx1/PfPdx2H196N complex (brown) reveals struc-
tural changes in the Pdx2 subunit upon complex formation. Regions that remain the
same in BsPdx2 and PfPdx2 structures after supersposition are ommited for clarity.
The structural differences are highlighted in red color and enclosed in rectangles: the
insertion sequence in plasmodial Pdx2 is shown as Loop 95-111. Loop 124-127 is disor-
dered in autonomous PfPdx2. The critical activation loop regions: loop Q12 (located
between β1 and α1) and loop OXH (oxyanion hole region) are highlighted. Both loops
in the plasmodial PLP synthase complex acquires a similar conformation like in the bac-
terial BsPdx2. Electron density 2mFo-DFc (blue, after refinement) and Fo-DFc (green,
before refinement) omit maps contoured at 1.2sigma and 2.2sigma, respectively, for each
respective region. Position of the active site shows the catalytic triad in stick represen-
tation.
3.3 Activation of the PLP synthase: helix α2’
and C-terminus of Pdx1 are key players in
catalysis
The Pdx1 C-terminus plays a key role in catalysis and oligomerization of the hex-
americ Pdx1 ring [18, 23]. It has low protein sequence conservation (Figure D.1),
although its biochemical function in catalysis seems to be conserved. Structure
of the full C-terminus is not known because of its high flexibility [13, 14, 18].
In this study, the solved PbPdx1 structure shows the C-terminus forming an
extended loop close to loop α2′-α2 of an adjacent Pdx1 monomer (Figure 3.14).
The 14 C-terminal residues are not defined in electron density of either PbPdx1
or PbPdx1 in complex with Pdx2. Deletion of 23 residues at the C-terminal
loop in PbPdx1 abolished I320 formation and therefore no PLP activity was de-
tected by enzymatic studies, without interfering with the glutaminase activity,
Table 3.8. However, dodecameric conformation of this deletion mutant was not
disrupted as seen for the wild-type PbPdx1 (Figure 3.15, upper panel), accord-
ing to the elution profile in size exclusion chromatography (Figure 3.15, lower
panel).
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I320 PLP synthesis Glutaminase
(% Activity) (% Activity) (% Activity)
PbPdx1 0.9 0.9 -
PbPdx1∆275 no activity no activity -
PbPdx1PbPdx2 1.2 1.5 179
PbPdx1∆275PbPdx2 no activity no activity 187
Table 3.8: Functional analysis of the PbPdx1∆275 deletion mutant. Specific activities
of I320 formation, PLP synthesis and glutaminase in the absence and presence of PbPdx2.
Figure 3.14: Architecture of the C-terminus in plasmodial Pdx1. Two Pdx1 protomers
are shown in light and dark blue. C-terminus of the subunit 2 is oriented toward the
adjacent Pdx1 in close proximity to helix α2’. Highlighted hydrogen bonds make contact
between subunit 1 and 2 along the C-terminus and loop α2′-α2. The dashed line repre-
sents one possible orientation the C-terminal region of subunit 2 might take towards
subunit 1. Covalently bound R5P to Lys 84 is shown as stick model.
To characterize the function of different regions of Pdx1 C-terminus in R5P
binding and PLP synthesis, several C-terminal deletion variants of P. falciparum
Pdx1 (Alignment shows the mutation position D.1) were analysed with respect
to PLP and hexamer/dodecamer formation. Contributions to this knowledge
were published in Derrer, et al 2010 [31]. The results demonstrated that 5 amino
acid residues after helix α8” are involved in R5P binding and I320 intermediate
formation, and efficient PLP synthesis requires the residues onward. Further-
more, formation of the hexamers requires the C terminal helix α8”, which helps
to maintain the oligomeric state of Pdx1. The PbPdx1 structure at 2.42 A˚
resolution is used here to describe the results. The C-terminus runs parallel to
the loop which connects α8 and α8’ of the same protomer (Figure 3.14). When
this C-terminal region was deleted, R5P binding was abolished. As helix α8’
is required to tighen R5P in the active site [13], the initial C-terminal segment
might assist α8’ in the sugar binding.
Furthemore, the C-terminus and loop α2′-α2 run parallel with each other (Figure
42
Figure 3.15: Purification of PbPdx1 and PbPdx1∆275 C-terminal deletion mutant.
Elution profiles PbPdx1 and PbPdx1∆275 from a Superdex S200 26/60 column. Upper
panel, elution profile of PbPdx1 shows two fraction peaks (A and B), evaluated by
SDS-PAGE (middle). PbPdx1 eluted at 151 ml, with a molecular mass of 352 KDa for
a dodecamer, calculated using the calibration curve shown in Figure 3.19. Rhomboid
crystals of PbPdx1 (right) were obtained with size ∼200 µm and diffracted to 2.5 A˚
resolution (Table 3.7). Lower panel, Elution profile of PbPdx1∆275 shows a fraction
peak (A) evaluated by SDS-PAGE (right). The deletion mutant eluted at 154 ml, with
a molecular mass of 319.2 KDa for a dodecamer, calculated using the same calibration
curve as PbPdx1. Theoretical values for one protomer of PbPdx1 and PbPdx1∆275
are 32.689 and 30.17 KDa, respectively, calculated with the http://www.uniprot.org/
server, accession code of PbPdx1: Q4Z0E8.
3.14), forming two main hydrogen bond contacts with distances of 2.9-3.3 A˚: two
nitrogens of two peptide bonds right after α8” with the carboxyl group of Asp66
43
in loop α2′-α2, and the guanidinium group of Arg63 with the carbonyl group
of Met 278 peptide bond at the C-terminal loop. Arg63 is a highly conserved
residue that might stablish an important contact to stabilize the conformation
of loop upward α8” at the adjacent subunit. Biochemical analysis of deletion
variants of Pf Pdx1 lacking the residues onward Met278 showed a decrease in
PLP synthesis. This C-terminal region is in close proximity to α2’ of an adja-
cent protomer (Figure 3.14), an additional segment involved in the initial steps
for R5P binding [14], it appears the C-terminus extends towards the adjacent
active site and assists in R5P binding, a cooperative regulatory process in Pdx1
core proposed by Raschle, et al 2009 [23].
Conformational changes in helix α2’ of Pdx1 [14] are important for PLP synthase
activation. The helix is ordered in the bacterial Pdx1 upon interaction with
Pdx2 and most likely prepares enzyme for catalysis [14]. In the plasmodial
Pdx1/Pdx2 complex solved at 3.6 A˚ resolution, α2’ is also ordered and seen in a
different orientation, compared with the Pdx1/Pdx2 structure from B. subtilis
(Figures 3.12 and 3.16). Since Pdx1 can bind R5P in the absence of Pdx2,
crystallization of PbPdx1 in the presence of R5P was tried to understand the
importance of this helix in the R5P binding. The Pdx1-R5P structure at 2.44 A˚
resolution showed the sugar covalently bound in the active site to lysine 84 and
α2’ is visible oriented towards the active site, closed to the sugar phosphate.
Hence, the three structural conformations of helix α2’ suggest that there is an
alternative positioning for this helix and this might be relevant with respect to
the catalytic cycle of covalent R5P attachment.
Figure 3.16: Ordering of helix α2’ for Pdx1 activation. A) Pdx1 alone showing lysine
84 as stick model. The loop region of α2’ is shown in blue. B) This pannel indicates
the position of helix α2’ as observed in the PbPdx1-R5P complex (blue) and in the
PbPdx1/PfPdx2 PLP synthase complex (dark-blue). Loops that change position upon
R5P binding towards the sugar phosphate are colored green, pink and yellow. Helix
α8’ is also shown, as this helix orients towards the sugar, as explained in § 3.5.1. The
covalently bound substrate ribose 5-phosphate on lysine 84 is represented as stick model.
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3.4 Ammonia enters through an “unrestricted”
tunnel in Pdx1
Ammonia is an essential substrate for PLP synthesis in the enzyme Pdx1. How
it enters to the active site is not really understood. Glutamine is a source of
ammonia when is hydrolysed by Pdx2 and can be substituted in vitro condi-
tions for ammonium salts e.g., NH4Cl and NH(4)2SO4. The Pdx1/Pdx2 com-
plex carries out a coupled reaction, in which glutamine hydrolysis by Pdx2
leads to production of ammonia, which subsequently reacts with R5P in Pdx1.
Since the two active sites are remote from each other, a model based on the
structure of B. subtilis Pdx1 was proposed and suggested that ammonia might
enter the β-barrel under the movement of flexible methionine residues [14]. The
Pdx1 structure from P. berghei solved in this study shows that some methio-
nine residues vary with respect to the position or conservation when compared
to the bacterial Pdx1 (Figure 3.17, compare left and right in B). Enzymatic
experiments were done in order to investigate the functional role of the residues
within the β-barrel in ammonia transfer.
Methionine residues involved in ammonia transfer from Pdx2 to Pdx1
Helix αN of Pdx1 was assigned as a key segment placed at the interface of both
subunits, probably as the gate for ammonia entrance from Pdx2. Superposition
of Pdx1 from B. subtilis alone and from the complex with Pdx2 showed no mayor
changes in the conformation of αN, despite some side chain residues of the helix
are not fully resolved in the autonomous BsPdx1 [14]. However, the functional
groups of two methionines (Met #13 and #16) on the helix displayed different
conformation in the two Pdx1 structures (figure 3.17, B right). Mutation of
Leu30 in Arabidopsis thaliana, a residue in equivalent position to Met13 in
B. subtilis, reduced the coupling between Pdx1 and Pdx2 by increasing the
glutaminase activity [50]. The PbPdx1 structure solved in this study has a
tryptophan in place of Met13 (Trp16), which is conserved in all plasmodial
Pdx1 proteins (see Alignment D1). Met16 on the contrary, is conserved in
the P. berghei Pdx1 (corresponds to Met19) and other Pdx1 proteins and in
the PbPdx1 structure adopts a similar conformation (Figure 3.17, A) to the
one seen in the B. subtilis Pdx1 alone (Figure 3.17, B left). This Met19 was
mutated to valine (based on the inactive Pdx1.2 of A. thaliana) and the PLP
synthase activity was evaluated with and without PbPdx2. The mutant had
an increase of PLP synthesis in the absence of Pdx2 and produced a similar
amount of PLP like wild-type in the presence of the glutaminase (Figure 3.18).
Ammonia uptake from Pdx2 was efficient, despite the decrease of glutaminase
activity in PbPdx2 (Figure 3.18).
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PLP synthesis PLP synthesis Glutaminase activity
with NH4Cl with Pdx2/Gln (% Activity)
as NH3 donor as NH3 donor
(% Activity) (% Activity)
PbPdx1 0.9±0.0 (100) 1.4±0.2 (100) 183±6 (100)
M19V 2.0±0.8 (222) 1.8±0.1 (130) 87±1 (48)
M46I 1.5±0.2 (161) 2.8±0.8 (207) 294±15 (155)
L82A 0.3±0.2 (28) 1.2±0.1 (89) 115±12 (63)
L82S 0.3±0.0 (34) 1.3±0.1 (93) 194±20 (104)
L82F 0.4±0.3 (44) 1.2±0.9 (89) 138±15 (74)
L82M 0.7±0.2 (72) 1.2±0.2 (82) 179±3 (96)
M103A 0.3±0.0 (34) 0.4±0.1 (30) 178±18 (97)
M103F no activity no activity 126±37 (69)
M148L 0.8±0.4 (89) 3.7±1.2 (274) 229±7 (125)
Figure 3.18: Functional analysis of residues in NH3 tunneling in PbPdx1. Specific
activities are indicated in nmol/min.mg for PLP synthesis of the NH3 tunnel mutants
in the absence and presence of PbPdx2. Glutaminase specific activities were also de-
termined in nmol/min.mg with corresponding NH3 tunnel mutants. Percentage of PLP
synthesis and glutaminase activities were calculated based on the wild type (PbPdx1 or
PbPdx1/PbPdx2) specific activities and displayed in a bar plot: light blue, variants using
NH3 from NH4Cl source; dark blue, variants using NH3 from L-glutamine hydrolyzed
by Pdx2, and brown, glutaminase activities in the presence of the NH3 tunnel mutants.
Residues in the β-barrel of PbPdx1 are organized in three layers represented in
Scheme 3.17, A. The bottom layer is constituted by Ile25, Leu82, M103, M148
and Phe213. The two residues Leu82 and Met103 are exchanged among Pdx1
proteins by a conserved Met or an aromatic residue (Tyr or Phe), respectively
but conserved among plasmodial Pdx1s (see Alignment D.1). An example is
shown in BsPdx1 (figure 3.17). The middle layer is formed by conserved residues
Met46, Val129 and Phe236 (see Alignment in D.1). The upper layer at the C-
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terminal end of the β-barrel has invariant residues of the active site, described
in more detail in § 3.5.
Interestingly, the reciprocal amino acid exchanges of PbPdx1Met103 for BsPdx1
Tyr100 at the bottom layer and PbPdx1Trp16 for BsPdx1Met13 in αN give the
plasmodial Pdx1 ammonia tunnel a different construction, compared to the B.
subtilis protein. At the interface of αN and bottom layer of the PbPdx1 barrel,
a cavity is visible protruding at the proximity of Leu82, Met103 and Met148,
when the tunnel is probed with a solvent surface radius of 1.2 A˚ (Figure 3.17, C).
This cavity is not seen in the BsPdx1 barrel (Figure 3.17, D). To understand
the function of the residues aligned within the barrel, point mutations were
introduced by site-directed mutagenesis. The ability of the variants to produce
PLP was tested in the absence and presence of Pdx2. Replacement of Met103
for Phe (based on the occuring of this residue in TmPdx1) and Ala resulted
in no (Figure 3.18) or halved PLP synthesis, respectively. Pdx2 glutaminase
activity in the presence of the PbPdx1M103F mutant was decreased to half of
the activity. Replacement of Leu82 with Met (highly conserved residue in other
Pdx1s) did not show difference in the PLP synthesis activity in the ammonia
or Pdx2-dependent reactions. On the contrary, L82A, L82S or L82F showed
significant changes in PLP synthase activities in the range of 50 % in the absence
of Pdx2 (Figure 3.18), restoring their activities in the presence of Pdx2 (Figure
3.18). However, the exchanged Met148 and Met46 residues for Leu and Ile,
respectively, led to two-three fold production of PLP when Pdx2 supplied the
ammonia. The variant Met46Ile had also an increased PLP synthesis in the
ammonia-dependent assay, suggesting this residue functions in ammonia transfer
but not in Pdx1/Pdx2 comunication. The results suggest that residues at the
lower layer (L82 and M103) might function as a control point for ammonia
uptake, and more precisely at M103 position according to the lost or decrease
PLP synthase activity when the residue is mutated to Phe or Ala, followed
by the conserved M46 and M148. These two methionines would control the
ammonia movement once it enters the tunnel, otherwise their mutations would
not make more accessible the tunnel for ammonia.
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3.5 Insights into the reaction mechanism of PLP
biosynthesis in Pdx1
Biosynthesis of PLP de novo in Pdx1 involves a chemistry currently described
by Hanes et al 2008 [21, 52]. The authors characterized three key intermediates
by NMR studies, incubating Pdx1 with 13C and 15N labeled substrates in a
stepwise manner to prove: firstly, R5P or Ru5P adduct intermediate is bound
to Pdx1 through its C1 carbonyl at the early steps of the reaction; this revises
an earlier finding in the crystal structure of T. maritima at 2.9 A˚ resolution,
where the sugar was thought to bind through a Schiff base at the C2 atom
[13]. Secondly, it was confirmed that a chromophoric intermediate (I320) with
maximum absorbance at 315 nm previously observed by Raschle et al 2007 [22]
is bound to Pdx1 via C5, suggesting a C1 to C5 imine migration. And thirdly,
a final intermediate formed after addition of G3P was characterized as PLP
bound through C5 to Pdx1 via an imine. These characterizations permitted to
construct the several chemical steps in the PLP synthase mechanism as shown
in Figure 1.6.
The highest resolution structure at 1.62 A˚ of Pdx1 deposited in the Protein
Data Bank (http://www.pdb.org/, PDB entry 2ZBT) belongs to the extreme
thermophile Thermus thermophilus from the HB8 strain. T. termophilus is a
gram-negative bacterium that can grow at temperatures from 50◦C to 82◦C [53].
To gain insight into the sequence of the chemical reactions that encompasses
PLP biosynthesis in the R5P-dependent route at atomic resolution, Pdx1 protein
from this organism was cloned, expressed and purified as described in § 2.1 and §
2.2 (Figure 3.19), with the expectation to produce diffracting crystals at higher
resolutions than the obtained with plasmodial PbPdx1-R5P complex.
The protein was crystallized under the conditions specified in Table 2.2, using ∼
1 mM of protein. Crystals for different experiments were soaked in ligands with
10 to 15 excess for R5P or PLP than protein concentration.2. Data collection
statistics are listed in Table 3.9.
3.5.1 Architecture of the active site in PLP synthase: R5P
binding state
In previous work, elucidation of the bacterial 3D Pdx1 structure at 2.9 A˚ (PDB
2ISS, [13]) in the presence of Ru5P allowed to assign the active site and the
residues possibly involved in the sugar binding and catalysis [13]. This site was
located at the C-terminal region of the β-barrel and was referred to P1, consti-
tuted by highly conserved residues: D23, K80, D101, S103, Arg146, G152, G213,
G234 and S235, see Alignment D.1. The TtPdx1-R5P complex structure solved
in this study at 1.7 A˚ resolution higher than the TmPdx1-Ru5P complex struc-
ture gave additional details of the sugar binding site, P1. At the early steps of
2nomenclature of amino acid residues mentioned throughout this § 3.5 are from T. ther-
mophilus Pdx1
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Figure 3.19: Elution profile and purification of TtPdx1. Elution profile of TtPdx1
from a Superdex S200 26/60 column shows a fraction peak of 147 ml with molecular
mass of 400 KDa calculated using the calibration curve (right). Theoretical value of one
TtPdx1 subunit is 32.026 KDa (accession code Q5SKD9 http://www.uniprot.org/).
The molecular weight for a dodecamer is 384.312 kDa (peak 147 ml). Evaluation of the
fraction peak by SDS-PAGE is shown (middle).
tt6-2 i20-5
Pdx1-R5P Pdx1-PLP
Space group R32
Unit cell a, b, c (A˚) 183, 183, 97
α, β, γ (◦) 90, 90, 120
Solvent content (%) 51
# mol in AU 2
Resolution (A˚) 46 - 1.7 90.9 - 2.1
Unique reflections 62742 77155
Rmerge 19.8 - 98.1 19.8 - 32.6
Completeness (%) 99.8 99.0
I/σI 4.5 - 2.5 4.7 - 2.4
Redundancy 8.4 4.7
Refinement
Rfree (%) 21.7 27.8
Rwork (%) 17.1 21.7
# of amino acids 552 548
#Water 732 351
# ligands 2a 2b, 2c
Ramachandran most favored (%) 94 93.3
Ramachandran additional allowed (%) 5.6 6.5
Ramachandran generously allowed (%) 0.2 0.1
Ramachandran disallowed (%) 0.2 0
RMSD bonds (A˚) 0.026 0.022
RMSD angles (◦) 2.1 1.9
Table 3.9: Crystallographic analysis of the TtPdx1 structures. Rmerge, Rwork and
Rfree are defined in equations 2.4 and 2.5.
a values were calculated for R5P ligand. b and c values were calculated for PLP and
phosphate ions, respectively. Rfree was calculated by excluding 5% of the experimental
data.
PLP biosynthesis, R5P is opened, by an still unknown mechanism, with forma-
tion of an R5P adduct at TtPdx1Lys80 and loss of H2O, as was demonstrated
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by mass-spectrometry analysis in BsPdx1 [22]. The hydrolysis occurs to lead
a Schiff base linkage between the ε-N of Lys80 and the C1 carbonyl of R5P.
This adduct has a visible electron density in the active site before refinement,
when the map is contoured with 2σ (Figure 3.20, green map). Modelling of the
sugar in the electron density and further refinement cycles, led to the backbone
of the sugar well fitted into the density. Its carbonyl group at C2 is visible
and not at C1 (Figure 3.20, light map), whose carbonyl would be expected to
be lost during the imine reaction. A water molecule represented by water 1
in Figure 3.20 (see also the diagram in the same figure) is well defined at the
high resolution electron density, forming hydrogen bonds with the ε-N of Lys80,
Asp101 and Ser103. Asp23 is positioned closer to the hydroxyl group of C2 of
the R5P adduct. Although Asp23 does not form direct contact with the sugar,
it might function in general acid/base catalysis, because its mutation (i.e., in
B. subtilis and P. falciparum Pdx1 [14, 54]) inactivated the PLP synthesis in
Pdx1, confirming its catalytic importance.
Comparison of the apo and TtPdx1-R5P structures shows that sugar binding
induces several conformational changes in the surrounding of the P1 site (Figure
3.20). These structural changes lead to the formation of a pocket, where the
phosphate group of R5P forms H-bonds with: the nitrogen of the peptide bond
of three glycines (G152, G213 and G234), the hydroxyl group of S235 and three
water molecules 2, 3 and 4 (Figure 3.20). The residues orient towards the
phosphate ion i.e., residues G234 and S235 in helix α8’ and G156 in loop β6-α6
(Figure 3.20). Helix α2’ also is displaced to the bound sugar (as seen in the
PbPdx1 structure, Figure 3.16) and closes the active sites.
3.5.2 From P1 to P2: PLP synthesis
A second active site in Pdx1, named P2, was predicted to be composed by
H114, R129, E137, R136, R137, K148 and K186 from a neighboring subunit
(Figure 3.21) based on TmPdx1 structure [13]. Recently, H114, R136 and R137
were confirmed to be required for PLP synthesis [30]. After R5P ring opens in
P1 site, an imine adduct is formed. Ammonia enters P1 active site and reacts
with the ketone of the adduct. This reaction releases water, forming a second
imine in C2 with the incoming ammonia, Figure 1.6. The reaction would follow
a phosphate elimination that leads to the I320. A particular chemical step of
imine migration was described in the PLP reaction mechanism [21]: the imine
linkage between Lys80 and the adduct shifts from the C1 to C5 position, Figure
1.6). It would represent a mechanism for the movement of the intermediate to
the P2 active site. As Lys148 is located at P2 site of Pdx1, it was proposed
earlier that Lys148 main chain would rotate and approach the P1 site [13]. The
reaction proceeds from the chromophoric I320 intermediate to PLP synthesis by
addition of G3P. A free form of PLP in the active site has been reported in P2 of
the yeast Pdx1 structure [55], but not explanation was given about the reaction
step that leads to the release of PLP nor the residues implicated in catalysis.
To gain insight into the PLP formation site, Pdx1 crystals were soaked in PLP
solution. The obtained TtPdx1-PLP structure at 2.1 A˚ resolution showed an
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Figure 3.20: R5P bound state in the active site of Pdx1. A) Electron density maps
FoFc (green mesh) before refinement and 2FoFc (light mesh) after refinement of R5P
bound to Lys80. B) Two views of the active site of TtPdx1 (blue) at 1.7 A˚ resolution
with refined electron density of Lys80 bound to opened R5P. The FoFc and 2FoFc maps
are contoured with 2.5σ and 1.2σ, respectively. Apo Pdx1 structure (grey) is used to
observe the conformational changes upon R5P binding in helices α2’, α8’ and loop β6-
α6. Catalytic residues are represented in sticks. Waters (yellow dots) are enumerated:
1, 2, 3 and 4, according to the scheme shown below. Bottom panel, schematic diagram
of R5P-Lysine interaction in P1 active site of Pdx1. Residues and waters in contacto to
Lys80 bound to the C1 of opened R5P via a Schiff base are shown with the hydrophobic
interactions and hydrogen bonds and respective length.
electron density protruding from Lys148 (Figure 3.22, A) with similar shape to
the pyridinium ring of PLP. PLP was modelled in the density and refined. The
resulting structure shows PLP forming an imine bond with its C4’ and the ε-N
of Lys148 (Figure 3.22, B). In this PLP-Pdx1 complex clearly the side chains of
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Arg136 and Arg137, as well as Lys186 from an adjacent protomer are in polar
contacts with the phosphate of PLP (Diagram 3.22).
Figure 3.21: P1 and P2 active sites of Pdx1 with R5P bound in P1. A Pdx1 subunit
with the two active sites highlighted in green (P1) and blue (P2) with respective catalytic
residues in stick representation. R5P covalently bound to Lys80 in P1 and phosphate
ion in P2 are shown in stick representation.
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Chapter 4
Discussion
Direct de novo biosynthesis of pyridoxal 5’-phoshate requires the three substra-
tes ribose 5-phosphate, glyceraldehyde 3-phosphate and L-glutamine as a source
for ammonia. The biochemical mechanism consists of the condensation of the
two phosphorylated sugars with ammonia in the PLP synthase. The mayority of
the knowledge available to date about the enzyme describes the activation mode
of Pdx2, in which Pdx1 is essential to induce glutamine hydrolysis. However,
Pdx1 catalyses most of the chemical steps for PLP biosynthesis and it needs to
be understood how the enzyme is activated in order to carry out the catalytic
reactions to finally synthesize PLP.
4.1 Activation of the PLP synthase
R5P entrance and organization of the catalytic center for enzyme
activation
R5P binding entails reorganization of the active site, in which segments such
as, helices α2’ and α8”, move towards the sugar. The structural changes in-
duce the formation of several hydrogen bonds with the substrate mainly at the
phosphate group. This leads to the formation of a closed environment surroun-
ding the sugar (Figure 4.1). Earlier structural studies showed that helix α2’
is ordered when Pdx1 interacts with Pdx2 [14, 13] and this was later assumed
to occur as an allosteric effect induced by Pdx2 to enhance R5P binding [23].
There are three structural states for α2’ described in this study, which explain
how helix α2’ functions in the activation of the PLP synthase. The helix is
disordered in the PbPdx1 structure and orders in the plasmodial Pdx1/Pdx2
structure. Interestingly, the helix is seen in a different position, when com-
pared to bacterial Pdx1/Pdx2 complexes and does not cover the P1 site. Here,
this state is proposed as the open conformation of α2’ to allow access for R5P.
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Co-crystallization of the plasmodial PbPdx1-R5P complex showed a third con-
formation of the helix, closer to what was observed for bacterial PLP synthase
complexes from B. subtilis and T. maritima [14, 13]. When the sugar enters the
catalytic center, it binds convalently to lysine 84 and helix α2’ closes the active
site. It explains helix α2’ has a crucial function in sequestering the substrate
intermediate from the solvent, most likely to prepare the enzyme for further
catalytic steps.
OH OH
OH
O
O
O P
O
N
O
NH
O NH
O
G238
S239
HN
H
D27
K84
G156
G217
�2' �8'
Figure 4.1: Scheme for R5P binding in the active site. The open R5P is attached
to Lys84 with its C1 atom. H-bonds are shown between the phosphate group and
residues G217, G238 and S239. H-bonds with G156 can also be formed (not shown).
Displacement of α2’ and α8’ induced by R5P binding are indicated by arrows. Asp27
is shown as a potential residue involved in isomerization of the R5P adduct into Ru5P
intermediate, as this residue is seen in close proximity to the oxygen atom of C2 in the
R5P-Pdx1 complex.
The activation mechanism of Pdx1 seems to be supported by simultaneous intra
and inter subunit communication in the Pdx1 core, by the C-terminus of a
Pdx1 protomer. This assumption is not a direct interpretation from the crystal
structures of Pdx1 proteins solved in this study or from other known structures,
in which the C-terminus is partially resolved in the electron density. Instead,
biochemical and mass spectrometry analyses carried out in C-terminal deletion
mutants of Pf Pdx1 showed that the five residues dowmstream of helix α8” of
the C-terminus (Figure 4.2), are essential for R5P binding and therefore PLP
synthesis (results published in [31]). This result and the available data of the
partially C-terminal region seen in the P. berghei Pdx1 structure, are consistent
to assign a function to the C-terminus of Pdx1 in catalysis. The C-terminus of
one Pdx1 subunit forms an extended loop at the interface of the adjacent Pdx1
subunit. The cooperative mechanism for PLP biosynthesis might occur by the
active role of the C-terminus in pentose binding at two active sites: firstly,
mediating the displacement of the N-terminal dipole of helix α8’ towards the
substrate phosphate of the same subunit with its initial region (Figure 4.2),
and secondly, assisting in sugar binding at the neighboring protomer with the
onward region (Figure 4.2), by repositioning helix α2’.
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region involved in �8' displacement 
towards the substrate phosphate
-COOH
region involved in PLP synthesis 
at the adjancent protomer 
5 ~20 (dependending on Pdx1 protein)
Figure 4.2: C-terminal regions of Pdx1 involved in catalysis. The length of two regions
with assigned functions are indicated.
4.1.1 Intermediates of the PLP synthase reaction
mechanism
Biochemical evidence for NH3 tunneling in the β/α-barrel
The PLP synthase is classified as a glutamine amidotransferase with two remote
active sites, one for the ammonia production and the other for PLP synthesis.
The resulting ammonia from glutamine hydrolysis in Pdx2 is channeled to the
Pdx1 active site [14] by an unknown mechanism. Structural analyses proposed
methionine residues are involved in NH3 transfer. Pdx1 is functional in the
absence of Pdx2 under in vitro conditions in the presence of ammonium salts.
Furthermore, enzymatic reports have shown that deletion of helix αN of Pdx1,
a key segment for glutaminase activation, does not affect PLP synthesis in
ammonia-dependent reactions [14, 55]. The ability of Pdx1 to function in the
absence of Pdx2, even when lacking its helix αN, indicates the N-terminal side of
the β-barrel functions as the ammonia gate. The Pdx1 β-barrel is hydrophobic
and encloses the appropiate environment for the passage of reactive ammonia.
However, a defined route within the β-barrel to connect the two active sites
is not discernible, suggesting opening of the tunnel is transient for ammonia
transfer.
Several residues at the inner side of the barrel or within helix αN terminus were
exchanged by site-directed mutagenesis in PbPdx1 and resulting proteins were
evaluated by enzymatic assays. The results from these assays gave evidences
the β-barrel channels ammonia to the acceptor intermediate in the P1 active
site. They also explained which residues are required for ammonia transfer. The
residues were chosen based on structural analysis for two reasons: 1) because
they showed changes in side chain conformation upon Pdx1 and Pdx2 inter-
action; 2) to prove their function as the residues formed cavities in the β-barrel
that would form - in principle - the place of ammonia. The variants indicated the
β-barrel of Pdx1 plays a role in ammonia tunneling, as shown by their significant
changes in the PLP synthesis rate. The ammonia tunnel residues were grouped
here according to three functions: i) residues involved in the uptake of nascent
ammonia from the Pdx2 active site e.g., Met19; ii) residues of the ammonia
gate in Pdx1 in the β-barrel (e.g., Leu82, Met103 and M148) and, iii) residues
controling the ammonia transfer to the catalytic center (e.g., Met46). Met19
showed to be involved in glutamine hydrolysis, since a severe effect was observed
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on glutaminase activity of Pdx2 on exchanged of this residue. Met19 lies on αN
helix exposed to the Pdx2 catalytic center, close to the peptide required to sta-
bilize the oxyanion region formed during glutamine hydrolysis. It appears this
methionine has an influence on the arrangement of the Pdx2 active site, forming
a path for the nascent ammonia. The ammonia would then pass helix αN and
encounter the ammonia gate at the bottom of the β-barrel. This gate consists
of Leu82, Met103 and Met148. Mutations of Leu82 and Met103 showed notable
defects in ammonia-dependent PLP synthesis, restoring the enzymatic activity
in the Leu82 mutants when ammonia was supplied from the glutaminase. In-
terestingly, Met103 was unique in this respect showing drastic activity loss in
the Pdx2 dependent and independent assays, when substituted either by Phe or
Ala. Introduction of a bulky side chain blocked the tunnel completely, however
a replacement for alanine still showed a decrease to less than 50% PLP acti-
vity with a minor effect on the glutaminase rate, suggesting Met103 serves as
a control point for ammonia uptake. An interesting result from the Met148Leu
variant showed that the PLP synthesis rate increased aproximately five-fold in
the glutaminase-dependent assay, therefore this residue directly links glutamine
hydrolysis, ammonia transfer and PLP synthesis. The path for ammonia is
followed by Met46, which is close to the catalytic Lys84 at the upper part of
the β-barrel. Replacement of this conserved methionine upregulated the PLP
synthesis in both enzymatic assays, suggesting ammonia can move within the
β-barrel until it encounters Met46, which controls the ammonia entrance to the
catalytic center of Pdx1.
R5P binding at the catalytic center
Earlier steps of the PLP biosynthesis require the catalytic reaction of R5P with
a lysine in the P1 site followed by isomerization of the R5P adduct. NMR ex-
periments demonstrated that the sugar is bound with its C1 carbon to the lysine
via a Schiff base [21]. In a recent investigation made by Moccand et al [30], it
was suggested that an arginine (Arg288, nomenclature of BsPdx1) positioned at
the flexible C-terminal region (not visible in Pdx1 structures) would coordinate
the binding of R5P at the adjacent protomer, by functioning as a general base
activated by Asp24 (nomenclature for B. subtilis) of Pdx1 [30]. The activated
Arg288 would function as a proton abstractor at C5 prior to phosphate elimina-
tion [30] on the way of the chromophoric intermediate formation. This residue
is not highly conserved and is substituted by lysine in plasmodial Pdx1 proteins
(Alignment D.1). The authors also tested an R288K variant which behaved as
the wild type. If the Arg functions as a proton acceptor, Lys might have the
same chemical function in plasmodial Pdx1 proteins. Crystallographic struc-
tures of PbPdx1 and TtPdx1 solved in this study confirmed the R5P substrate
is attached to the catalytic lysine with its C1. The aspartate is in close proximity
to the C2 carbon of the R5P adduct in the active site, indicating the aspartate
might be the proton acceptor from the hydroxyl group of C2 for R5P adduct
isomerization into Ru5P. Arg288 could function in substrate isomerization and
not for proton shuﬄing at C5, more precisely, as a proton acceptor at Asp24
subsequently Asp24 functioning as a base in the isomerization to give a carbonyl
group at C2.
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Intermediate migration from P1 to P2: PLP biosynthesis
The enzymatic reaction after R5P binding continues when the second substrate,
NH3, reacts with the pentose adduct to form the chromophoric intermediate I320
after release of water and phosphate ion. The question was if the final steps of
PLP biosynthesis take place in the P2 site of Pdx1 and Lys152 (nomenclature
for PbPdx1) is involved in the chemical reactions, how the intermediate would
be transfered from P1 to P2. A proposed mechanism was suggested after elu-
cidation of the bacterial PLP synthase in complex with an Ru5P adduct and
later supported by chemical analyses with NMR experiments [13, 21]: since
Lys152 is located in the P2 site, the residue would have to rotate and approach
the P1 site [13], to reposition the intermediate in a new environment [21, 56].
This residue was confirmed to play a role in catalysis, as mutants of it were
unable to synthesize PLP [13, 22]. Interestingly, mutation of this lysine into
arginine did not hinder the enzyme to produce I320, unlike mutation to alanine
that incapacitated Pdx1 to produce the chromophoric intermediate [22]. This
finding was an initial indication that Lys152 might play a role in catalysis and
has been recently confirmed by electrospray ionization mass spectrometry stud-
ies [30]. The Pdx1-PLP structure solved in this work shows the PLP attached
with its C4’ carbon to the catalytic lysine via a Schiff base in the P2 site, giving
structural evidence of the P2 site for PLP biosynthesis. Still, it is unclear at
what stage of the reaction the intermediate is transfered from P1 to P2, where
the PLP is observed. The mechanism remains to be characterized by which the
imine migrates from C1 to C5. A hypothetical mechanism based on [21, 56] is
illustrated in Figure 4.3.
NH2
O
N
K84
K152
NH
P1 site
P2 site
C5C1
NH2
rotation of the lysine
Figure 4.3: Proposed mechanism for migration of the intermediate to P2 site. As
postulated by Hanes et al 2008, an imine migration mechanism takes place from C1
to C5 of the intermediate. Lys152 approaches P1 site by rotation and reacts with the
intermediate at C5.
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4.2 Assembly of the PLP synthase complex
Studies of the multienzymatic assembly of the PLP synthase complex are sparse.
The structural and biochemical data available show the full assembly of the
enzyme forms a complex of up to ∼700 kDa [13, 14, 18, 31] and the asso-
ciation of the Pdx1 or Pdx1/Pdx2 subunits relies on critical structural and
functional segments. The core of the PLP synthase complex is constituted by
Pdx1 forming a dodecamer, as seen in the crystal structures of bacterial Pdx1
[13, 14]. However, hexamers can be formed in solution for bacterial and euka-
ryotic systems [13, 14, 31], and smaller oligomers are absent. The Plasmodium
structure solved in this study confirms that eukaryotic Pdx1 proteins, in general,
can assemble into dodecameric structures, in contrast to the yeast Pdx1 from
S. cereviciae that was hexameric in the crystal structure and almost exclusively
hexameric in solution [18]. The presence of a unique sequence insertion in the
yeast Pdx1 protein is responsible for the different oligomerisation behavior [18].
The Pdx1 complex assembly depends on the additional helices that surround
the (β/α)8 barrel and delimit the interface of the hexamer/dodecamer [18, 31].
This assembly determines a catalytically active complex as the Pdx1 quater-
nary conformation is required for pentose substrate binding and catalysis in a
cooperative manner [23, 31].
Pdx2 assembles randomly to the Pdx1 dodecameric core
The mechanism by which Pdx2 assembles to the Pdx1 core has not been studied
in detail. Fully occupied PLP synthase complexes could be obtained in vitro
using substrates of the enzymes (Ru5P or glutamine), which allowed crystal
structure determination [13, 14] and in this study (Figure 4.4, A). Biophysical
studies have shown the substrate glutamine streghtens the Pdx1/Pdx2 inter-
action in prokaryotic and eukaryotic complexes [14, 15, 33]. All tested PLP
synthase complexes from B. subtilis [33], P. falciparum [15] and P. berghei show
a high entropy gain in the absence of glutamine that decreases when glutamine
is added to the system, suggesting Pdx1/Pdx2 complexes lose conformational
freedom tending to the stabilization of the complex. Furthermore, an increase
of enthalpy change occurs in the presence of glutamine, most likely due to the
additional interactions formed at the protein-protein interface and glutamine
binding in the active site. Hence, it can be deduced that the substrate glu-
tamine modulates the complex formation by entropy loss and enthalpy gain.
The mechanism by which the two enzymatic subunits associate / dissociate in
the presence of glutamine is not discernible from the ITC studies. It is unknown
whether glutamine binding modulates the assembly of Pdx2 with Pdx1 in the
complex, as the ITC assays tested complexes using the catalytic inactive Pdx2
to stabilize the complex. Previous pull out assays to analyse the interaction of
native Pdx1 and His-tagged Pdx2 from B. subtilis in the presence of acivicin [12]
showed that Pdx1/Pdx2 complexes were no longer formed after preincubation
of the proteins with acivicin. Particularly, it was observed that the complexes
dissociated due to transient interactions, allowing Pdx2 to bind acivicin and the
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modified acivicin-Pdx2 complexes could not longer interact with Pdx1. Crystal-
lization studies of the B. subtilis Pdx2 in complex with acivicin showed that the
relevant regions for complex formation and Pdx2 active site organization are
distorted [57]. These structural changes caused by acivicin alter the protein-
protein interface, decreasing the affinity of Pdx2 with Pdx1 and therefore, a
Pdx1 and Pdx2 interaction analysis with acivicin is not compatible to explain
the assembly of the PLP synthase complex.
Visualization of the PLP synthase complex by electron microscopy analysis
proves that Pdx1 and Pdx2 assemble transiently. Few Pdx2 subunits occu-
pied the Pdx1 dodecameric core, without a defined pattern for this association,
despite the presence of glutamine in the assay. In contrast, fully assembled com-
plexes were observed, when the catalytic inactive Pdx2 was used. If the mea-
sured ITC data in the absence of glutamine are considered together with the EM
analysis using active Pdx2 and L-glutamine, it can be deduced the Pdx1/Pdx2
assembly has a high rate of association/dissociation and the substrate glutamine
does not modulate a subsequent binding of the Pdx2 subunits on the Pdx1 do-
decamer.
Substrates do not determine the Pdx1/Pdx2 assembly in vitro
GATases are regulated in several ways to control glutamine hydrolysis [9]. For
example, in enzymes such as, Anthranilate synthase [58], glucosamine 6- phos-
phate synthase [59] or imidazole glycerol phosphate synthase [60] the gluta-
minase domain requires an acceptor substrate bound to the synthase domain
to activate glutamine hydrolysis allosterically. It was reported earlier for the
PLP synthase complex that Pdx1 is sufficient to stimulate the glutaminase; ad-
dition of the Pdx1-substrates did not enhance the rate of glutamine hydrolysis
[12]. Moreover, it is known that Pdx1 catalyzes PLP synthesis with sub-optimal
activity, as observed in this study with Pf Pdx1 or PbPdx1; more precisely, the
glutaminase and synthase reactions seem not to be synchronized as most of the
produced NH3 is not used for PLP synthesis. Recent evidence shows PLP re-
lease from Pdx1 depends on the presence of a PLP-depedent enzyme [30] as a
regulatory mechanism to control PLP biosynthesis by Pdx1. Biochemical and
biophysical (ITC and AUC) analyses presented in this study show that Pdx2
can interact with Pdx1 independent of the substrates R5P or L-Gln. In par-
ticular, glutamine does not bind to Pdx2 alone, rather it requires a preformed
Pdx1/Pdx2 complex. This implies Pdx2 interaction with Pdx1 and glutamine
binding in the Pdx1/Pdx2 complex do not modulate PLP synthesis.
In summary, the interpretation that a Pdx1/Pdx2 complex is required for glu-
tamine binding, together with EM analysis leads to the proposal that the com-
position of Pdx2 can vary in the multi-enzymatic Pdx1/Pdx2 complexes and
would not require neighboring Pdx1 proteins to promote sequential occupancy
with Pdx2. In addition, encounter complexes can associate independent of the
presence of glutamine or NH3-acceptor substrate, i.e, Pdx2 can interact with
Pdx1, subsequently bind glutamine and hydrolyse it without an stimulatory
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signal provided by an NH3 acceptor and then Pdx2 leaves the complex (Figure
4.4, B). Another interpretation would be that Pdx2 binds Pdx1, hydrolyses glu-
tamine and remains in complex with Pdx1 in the presence or absence of an
ammonia acceptor (Figure 4.4, B). The resulting NH3 could be stored until
a substrate acceptor enters the active site. The synchronization of ammonia
transfer for PLP synthesis would be further regulated by a PLP-dependent en-
zyme.
+Pdx2
- Pdx2
Pdx1 dodecamer
Pdx1 hexamers
L-Gln
Glu + H2O
PLP synthase complexPdx1 dodecamer
Pdx1 hexamers
+ Pdx2 
+ L-Gln
inactive
+
Glu + H2O+
A) Assembly of the PLP synthase using catalytically inactive Pdx2 
B) Assembly of the PLP synthase in the presence of L-Gln and +/- R5P 
(+/- R5P)
Figure 4.4: Assembly of PLP synthase from Pdx1 and Pdx2 proteins.
Pdx1/Pdx2 interaction in prokaryotes and eukaryotes
The main motivation of this PhD Thesis was to obtain the crystal structure
from P. falciparum PLP synthase complex and understand how this enzyme
functions for its potential use in drug design to treat malaria. However, P. fal-
ciparum PLP synthase proved a difficult target for crystallographic 3D structure
determination due to the aggregation into fibers in vitro observed in electron
microscopic analysis, not seen with the proteins from the rodent parasite P.
berghei. The fibers were seen when using Pf Pdx1, which also aggregated into
fibers in the absence of Pf Pdx2, Figure 3.6. Comparison of the electrostatic sur-
face at the interface of two opposite Pdx1 subunits from the Pf Pdx1/Pf Pdx2
model1 and PbPdx1 dodecamer did not show differences in the contact of the
two Pdx1 proteins (Figure 3.9). One can speculate the C-terminus of Pf Pdx1,
that has eluded structural determination and has high protein sequence variabil-
ity, might be involved in the fiber formation, since it is known that this region
plays a key role in reciprocal activation between two Pdx1 subunits [23, 31].
Future investigations could use C-terminal deletion mutants of Pf Pdx1 in crys-
1structural model described in [15]
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tallographic and electron microscopy experiments to understand the cause of
Pf Pdx1 aggregation.
The observed aggregation into fibers was a limitant for continuing crystalliza-
tion trials with the P. falciprum PLP synthase complex. Instead, structural
studies were continued on a chimeric complex between P. berghei Pdx1 and
P. falciparum Pdx2. The proteins are highly similar, with more than 60%
identity in sequence among the autonomous Pdx1 and Pdx2 from both para-
sites. The complex sucessfully crystallized and diffracted to 3.6 A˚ resolution
and is composed of 24 subunits, as seen in the bacterial strutures [13, 14]. The
plasmodial Pdx1/Pdx2 chimera proved to be a proper system to study an euka-
ryotic PLP synthase complex because this reconstituted complex was functional,
hydrolysing glutamine and synthesizing PLP with catalytic rates similar to the
natural P. falciparum and P. berghei PLP synthase complexes.
Elucidation of the 3D structure from this eukaryotic complex revealed two major
advances related to enzyme interaction and activation: i) the importance of
insertion sequences for protein-protein interaction in eukaryotic systems, and ii)
the importance of key structural conformational changes in the interface for the
Pdx2 glutaminase activation, common in prokaryotic and eukaryotic systems.
The insertion sequences determine the differences in the Pdx1/Pdx2 interaction.
A particular loop named loop 95-111 [24] of Pdx2 was seen in the interface with
Pdx1. This region is prone to variation in eukaryotic proteins (Figure D.2)
and is absent in bacterial Pdx2, therefore the contact to Pdx1 is abolished. It
might explain why the strength of Pdx1/Pdx2 association between bacterial and
plasmodial Pdx1/Pdx2 interfaces is different in ITC experiments. Rigid body
rotation of Pdx2 was seen in the structure, compared to bacterial systems. This
should not be surprising, since changes in the shape of multi-subunit complexes
are common for the function and regulation of the proteins in the cell, e.g,
chaperonins [61, 62], piruvate kinase [63]. The structural alteration of the Pdx2
position in the chimeric complex could explain another step of the complex
formation process, as changes were also seen in the Pdx1 subunit, i.e., helix
α2’ was observed in an open conformation, discussed above § 4.1. Despite
this positional difference of the Pdx2 subunit, the active site is organized at
the interface with Pdx1, similar to the position observed for bacterial complex
structures. Its surrounding showed the same structural changes required for
Pdx2 activation such as, ordering of loop 124-127 and organization of the critical
oxyanion region, supported by the activation loops Q12 and OXH. This suggests
the mechanism of Pdx2 activation is conserved in prokaryotic and eukaryotic
proteins.
4.2.1 Targeting PLP synthase complex for drug design
Inhibitor-based approaches to combat diseases should be based on the premise
that the selected or designed inhibitors should target biological components ab-
sent in the host genome, in order to avoid harmful side effects with proteins
from the host. Vitamin B6 is essential for all living organisms. The mayority
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of organims can synthesize vitamin B6 de novo but humans must take it from
the diet. The genes pdx1 and pdx2 of the R5P-dependent pathway are present
in several pathogenic organisms, such as Plasmodium, Toxoplasma gondii [64]
and Mycobacterium tuberculosis [65, 66]. Recently it has been reported that
disruption of the pdx1 gene in M. tuberculosis is lethal for the bacterium [66].
Moreover, it has been reported that P. falciparum expresses pdx1 and pdx2
during blood stages [24], the ones that cause the malaria disease. The PLP syn-
thase Pdx1/Pdx2 complex from Plasmodium was studied here for its potential
use as a drug target.
Targeting the PLP synthase complex for drug design should be based on know-
ledge about the 3D structure of the enzyme more than substrate-based approa-
ches to avoid side effects because, the PLP synthase complex shares substra-
tes (R5P, G3P and Gln) with other essential metabolic enzymes eg., ribose 5-
phosphate isomerase2, glyceraldehyde 3-phosphate deshydrogenase3, glutamine-
PRPP4 amidotransferase5 [67]. Given that the assembly and activation of the
PLP synthase complex depends on α-helices such as, αN or α2’, these repre-
sent an useful information for drug development. Compounds such as small
peptides, designed to inhibit protein-protein formation must affect the protein
surface selectively, despite protein-protein interfaces having a large surface area.
For instance, approaches to disrupt the assembly of the hexameric gp416 core
using C-terminal heptad repeat peptides of HIV-1 gp41 have been successful
[68], and have been confirmed by x-ray crystallography from which the peptide
is shown bound to the hydrophobic pocket on the surface of HIV-1 gp41 [68].
Interestingly, Pdx1 and Pdx2 depend on each other for activation and also
to provide substrates to the other, marking the importance of the ammonia
tunnel entrance as a vulnerable site for drug design. This would circumvent the
problem of identifying drugs based only on protein-protein interaction. Taking
advantage of the fact that αN is fundamental for Pdx1/Pdx2 assembly and
is at the interface of the ammonia gate of the β-barrel, this region could be
considered for developing inhibitors of the PLP synthase complex, i.e., inhibitors
(e.g., compounds or peptides) that block the protein-protein interaction and
concomitant block the ammonia entrance to the β-barrel.
In addition to the above strategy, targeting the PLP synthase catalytic center in
Pdx1 would be suitable for structure-based inhibitor design for the following rea-
sons: PLP synthesis involves more than 20 enzymatic steps with intermediates
uncommon in other enzymatic processes such as I320. I320 is a very stable inter-
mediate and could guide drug development.
Studies of structure-based drug design will also enrich our understanding of the
PLP synthase reaction mechanism.
2an enzyme involved in the pentose phosphate pathway
3an enzyme involved in the breakdown of glucose in glycolysis
45-phosphoribosyl 1-pyrophosphate
5an enzyme involved in de novo purine nucleotide synthesis
6a glycoprotein of the HIV-1 envelope
Chapter 5
Future Directions
Plasmodial PLP synthase has emerged as an attractive drug target due to the
absence of this biosynthetic enzyme in humans. The possibility of translocation
of B6 vitamers from the host cell and conversion into PLP by the kinase PdxK in
the parasite is considered as a likely survival mechanism under PLP depletion,
although genetic manipulation trials are needed to prove that, i.e., knockdown
experiments of the gene encoding Pdx1 in the erythrocyte-infecting stages of the
malaria parasite to observe the requirement of Pdx1 for cell growth. Regardless
of alternative strategies to supply vitamin B6 to the parasite, PLP biosynthesis
seems to be an important pathway during the blood stages of P. falciparum,
because Pdx1 and Pdx2 proteins are expressed constitutively [24], and both
enzyme genes are upregulated when the parasite is subjected to oxidative stress
conditions [29].
Future investigations to provide additional knowledge of the enzymatic mecha-
nism of plasmodial PLP synthase e.g., PLP release from the Pdx1 catalytic
center, in the presence of PLP-dependent enzymes, might contribute in under-
standing enzyme regulation and its dependency on certain cellular conditions
eg., oxidative stress, PLP demands.
As electron microscopic studies proved to be an useful technique to gain insight
into enzyme assembly, additional experiments can be done with this technique
to visualize how substrates such as, R5P, G3P, or product like PLP, modulate
the Pdx1/Pdx2 assembly in vitro.
Elucidation of the PLP synthase 3D structure with its entire C-terminus would
improve the understanding of how residues of the C-terminus are involved in
the cooperativism of the Pdx1 core, for example, using cross-linkers “to trap”
the enzyme in a conformation with the C-terminus bound at the adjacent Pdx1
protomer.
Another interesting question to answer is whether Pdx1 synthesizes PLP in the
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absence of Pdx2 in vivo, as shown in the in vitro assays using ammonia sources.
In particular, characterization of the PLP biosynthetic mechanism by microspec-
trophotometry, substrate analogues and x-ray crystallography to get snapshots
of the catalytic steps as well as, advances in unraveling the molecular mechanism
by which ammonia is transfered along the (β/α)8-barrel in the PLP synthase,
can be used as basis for drug design against malaria.
Appendix A
Oligonucleotides
Table A.1: List of oligonucleotides used for cloning genes and point-mutants. Codon
mutations are highlighted and restriction sites for endonucleases recognition are under-
lined.
Name Oligonucleotide
PbPdx1M19V for CTTAAGCATGGATGGTGTGAAGTGTTAAAAGGGGGAGTCATAATG
PbPdx1M19V rev CATTATGACTCCCCCTTTTAACACTTCACACCATCCATGCTTAAG
PbPdx1M46I for GGCTGGTGCAATAGGTGTAATCATTTTAGAAAATATTCCATC
PbPdx1M46I rev GATGGAATATTTTCTAAAATGATTACACCTATTGCACCAGCC
PbPdx1L82M for GAAAATGCATTTCTATAAATGTAATGGCTAAAGTTAGAATAGGC
PbPdx1L82M rev GCCTATTCTAACTTTAGCCATTACATTTATAGAAATGCATTTTC
PbPdx1L82A for CATTTCTATAAATGTAGCAGCTAAAGTTAG
PbPdx1L82A rev CTAACTTTAGCTGCTACATTTATAGAAATG
PbPdx1L82F for CATTTCTATAAATGTATTCGCTAAAGTTAG
PbPdx1L82F rev CTAACTTTAGCGAATACATTTATAGAAATG
PbPdx1L82S for CATTTCTATAAATGTATCCGCTAAAGTTAG
PbPdx1L82S rev CTAACTTTAGCGGATACATTTATAGAAATG
PbPdx1M103A for GAACTCAAAGTTGATGCACTTGATGAAAGTG
PbPdx1M103A rev CACTTTCATCAAGTGCATCAACTTTGAGTTC
PbPdx1M103F for GAAGAACTCAAAGTTGATTTCCTTGATGAAAGTGAAG
PbPdx1M103F rev CTTCACTTTCATCAAGGAAATCAACTTTGAGTTCTTC
PbPdx1M148L for GAATATCAGAAGGAGCTTCTCTGATAAGAACCAAAGGTGAAGC
PbPdx1M148L rev GCTTCACCTTTGGTTCTTATCAGAGAAGCTCCTTCTGATATTC
PbPdx2H199N for ATTGTATGGGAACAATTTTTAACCCAGAATTAATGCCATAT
PbPdx2H199N rev ATATGGCATTAATTCTGGGTTAAAAATTGTTCCCATACAAT
TtPdx1NotIrev ATAAGAGCGGCCGCCCATCCTCTCTTTGCAAGCCTTTC
TtPdx1BamHINdeI for AAAAGGATCCATATGGAGGGCGGGATGGAAAAGGGC
PfPdx1BamHINdeI for GAAGAAGGATCCATATGGAAAATCATAAAGATGATGCAG
PfPdx1Stop XhoI rev CAACAACTCGAGTCATTGTGGTGTTAAAAATTTGGTG
PfPdx2H196NNheI for ACTAGTGGAGCTAGCATGTCCGAAATAACTATAGGGGTATTAT
PfPdx2H196NStop XhoI rev TAATAACTCGAGTTATGAATATTTGTAATTTTTAACCTTC
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Appendix B
Purification of Pdx2 from
P. berghei and P.
falciparum
Figure B.1: Elution profile and purification of PbPdx2H199Nby SEC. Elution profile of
PbPdx2H199N from a Superdex S200 26/60 column shows four fraction peaks (A, B, C
and D), which were evaluated by SDS-PAGE (left). Peaks A, B and C correspond to high
molecular weight aggregates. Monomers of PbPdx1 eluted at 250 ml, corresponding to a
molecular mass of 18 KDa. Theoretical value of PbPdx2H199N is 25.675 KDa (accession
code Q4PJX5 http://www.uniprot.org/). The calibration curve (middle) of the column
was performed as described in § 2.2.
69
70
Figure B.2: Elution profile of native PfPdx2H196N by AEC using a Source 30Q matrix.
PfPdx2H196N eluted from a 10-800 mM NaCl gradient at a concentration of 286 mM
NaCl (peak B).
Figure B.3: Elution profile and purification of PfPdx2H196Nby SEC. Elution profile
of PfPdx2H196N from a Superdex S200 26/60 column shows a fraction peak of 249 ml
with molecular mass of 18.2 KDa calculated using the calibration curve (middle). The
calibration of the column was performed as described in § 2.2. Theoretical value of
the molar mass of PfPdx2H196N is 24.563 KDa (accession code Q8IIK4 http://www.
uniprot.org/). Evaluation of the fraction peak by SDS-PAGE is shown (left).
Appendix C
Glossary
AEC Anion exchange chromatography
A Alanine
A˚ Angstro¨m
APAD 3-acetylpyrimidine adenine dinucleotide
At Arabidopsis thaliana
AUC Analytical ultracentrifugation
Bs Bacillus subtilis
C-terminal Carboxy terminal
D Aspartate
E. coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
e.g. exempli gratia
ESRF European Synchrotron Radiation Facility
EM Electron Microscopy
GATases Glutamine amidotransferases
G. stereaothermophilus Geobacillus stereaothermophilus
GF Gel filtration (Size exclusion chromatography)
L-Gln L-Glutamine
Glu Glutamate
G3P DL-glyceraldehyde 3-phosphate
G Glycine
i.e. id est
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HIV Human immunodeficiency virus
H Histidine
K Lysine
KCl Potassium Chloride
kDa Kilo Dalton
Leu Leucine
Lys Lysine
M Methionine
MTG 1-Thioglycerol
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NaCl Sodium Chloride
NaH2PO4 Sodium monobasic Phosphate
NH4Cl Ammonium chloride
(NH4)2SO4 Ammonium sulphate
N-terminal amino terminal
NCS Non crystallographic symmetry
NMR Nuclear magnetic resonance
Pb Plasmodium berghei
Pf Plasmodium falciparum
OXH Oxyanion hole
P Proline
PCR Polymerase Chain Reaction
PDB Protein data bank
PEG Polyethylene glycol
Phe Phenylalanine
PLP Pyridoxal 5’-phosphate
Pro Proline
R Arginine
R5P D-Ribose 5-phosphate
rmsd Root mean square deviation
S Serine
SEC Size exclusion chromatography
Tm Thermotoga maritima
Tt Thermus thermophilus
Tris Hydroxymethyl aminomethane
Tyr Tyrosine
wt Wild type
Appendix D
Alignments
The alignments were made using TEXshade [69]
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Figure D.1: Alignment of amino acid sequences of selected Pdx1 proteins. The sequences are tinted with the purpose
to highlight: putative residues of the ammonia tunnel (dark blue); residues of the α2’ helix (red); and residues involved
in substrate binding and/or catalysis in P1 (light green) and P2 (dark green). Enumeration is based on P. berghei
Pdx1, excepting R129 is for T. thermophilus Pdx1. Residues in light blue correspond to the βN region of the B.
subtilis and T. maritima Pdx1 proteins that interact with Pdx2 in the Pdx1/2 complexes. Arrows on top of the
alignment mark the position where deletion of the C-terminus were made in Derrer et al 2010. Sequence shading and
labeling were done using TEXshade package.
αN β1 α1 β2
o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^o^o^
P. falciparum ...............MENHKD.......DAVLLKHGWCEMLKGGVIMDVKSVEQAKIAEEAGAIGVMVLE 48
P. berghei ...............MRDYADN......DSILLKHGWCEMLKGGVIMDVKNVEQAKIAEKAGAIGVMILE 49
P. chabaudi ...............MKDYTDN......DSILLKHGWCEMLKGGVIMDVKNVEQAKIAEKAGAIGVMVLE 49
P. knowlensi ...............MEDHKEN......DSILLKHGWCEMLKGGVIMDVKNVEQAKIAEEAGAIGVMVLE 49
P. vivax .........MENAKRMDDHKDN......DSILLKHGWCEMLKGGVIMDVKNVEQAKIAEEAGAIGVMVLE 55
A. thaliana 1.1 .......MAGTGVVAVYGEGAMTETKQKSPFSVKVGLAQMLRGGVIMDVVNAEQARIAEEAGACAVMALE 63
A. thaliana 1.2 MADQAMTDQDQGAVTLYSGTAITDAKKNHPFSVKVGLAQVLRGGAIVEVSSVNQAKLAESAGACSVIVSD 70
A. thaliana 1.3 .......MEGTGVVAVYGNGAITEAK.KSPFSVKVGLAQMLRGGVIMDVVNAEQARIAEEAGACAVMALE 62
S. cerevisiae 1.1 ...............MTGE..........DFKIKSGLAQMLKGGVIMDVVTPEQAKIAEKSGACAVMALE 45
S. cerevisiae 1.2 ...............MS............EFKVKTGLAQMLKGGVIMDVVTPEQAIIAERAGACAVMALE 43
S. cerevisiae 1.3 ...............MS............EFKVKTGLAQMLKGGVIMDVVTPEQAIIAERAGACAVMALE 43
T. gondii .........MDQAATSAAASQR......GTARTKLGLAEMLKGGVIMDVMNVEQARIAEKAGACAVMALE 55
B. subtilis ..............MAQTG..........TERVKRGMAEMQKGGVIMDVINAEQAKIAEEAGAVAVMALE 46
G. stereaothermophilus ..............MALTG..........TDRVKRGMAEMQKGGVIMDVVNAEQAKIAEAAGAVAVMALE 46
T. maritima .............MEIKKG..........TWIIKKGFAEMFKGGVIMDVTSAEQAKIAEEAGAVAVMALE 47
T. thermophilus ...............MEKG..........TFQIKTGFAEMFKGGVIMDVTTPEQAVIAEEAGAVAVMALE 45
M. tuberculosis ...............MNTAHSPDGSGRTGTARVKRGMAEMLKGGVIMDVVTPEQAKIAEGAGAVAVMALE 55
↑ ↑ ↑ ↑
W16 M19 D27 M46
α2’ α2 β3 α3 β4
o^^ o^ o^ o^ o^^ o^ o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^o^o^
P. falciparum NIPSELRNKEGVARSVDPSKVEEIKKCVSINVLAKVRIGHFVEAQILEELKIDMIDESEVLTIADEMHHI 118
P. berghei NIPSELRNTDGVARSVDPLKIEEIRKCISINVLAKVRIGHFVEAQILEELKVDMLDESEVLTMADEYNHI 119
P. chabaudi NIPSELRNTDGVARSVDPLKIEEIRKCISINVLAKVRIGHFVEAQILEELKVDMLDESEVLTMADEYNHI 119
P. knowlensi NIPSELRSKESVARSVDPSKVEEIKKNVSINVLAKVRIGHFVEAQILEELKIDMIDESEVLTMADENNHI 119
P. vivax NIPSELRSKESVARSVDPSKVEEIKKSVSINVLAKVRIGHFVEAQILEELKVDMIDESEVLTMADENNHI 125
A. thaliana 1.1 RVPADIRAQGGVARMSDPEMIKEIKNAVTIPVMAKARIGHFVEAQILEAIGVDYVDESEVLTLADEDNHI 133
A. thaliana 1.2 ....PVRSRGGVRRMPDPVLIKEVKRAVSVPVMARARVGHFVEAQILESLAVDYIDESEIISVADDDHFI 136
A. thaliana 1.3 RVPADIRAQGGVARMSDPQMIKEIKQAVTIPVMAKARIGHFVEAQILEAIGIDYIDESEVLTLADEDHHI 132
S. cerevisiae 1.1 SIPADMRKSGKVCRMSDPKMIKDIMNSVSIPVMAKVRIGHFVEAQIIEALEVDYIDESEVLTPADWTHHI 115
S. cerevisiae 1.2 RIPADMRKSGQVCRMSDPRMIKEIMEAVSIPVMAKVRIGHFVEAQILEELQVDYIDESEVLTPADWTHHI 113
S. cerevisiae 1.3 RIPADMRKSGQVCRMSDPRMIKEIMEAVSIPVMAKVRIGHFVEAQILEELQVDYIDESEVLTPADWTHHI 113
T. gondii KIPADIRQSGGVARMSDPAMIEEIMKAVSIPVMAKCRIGHFVEAQVLAAIGVDFIDESEVLTVADEENHI 125
B. subtilis RVPADIRAAGGVARMADPTIVEEVMNAVSIPVMAKARIGHIVEARVLEAMGVDYIDESEVLTPADEEFHL 116
G. stereaothermophilus RVPADIRAAGGVARMADPTVVEEVMNAVSIPVMAKVRIGHYVEARVLEALGVDYIDESEVLTPADEEFHI 116
T. maritima RVPADIRKEGGVARMASIAKIREIMEAVSIPVMAKVRIGHIAEAKILEELGVDFIDESEVLTPADDRFHI 117
T. thermophilus RVPADIRAQGGVARMSDPKIIKEIMAAVSIPVMAKVRIGHFVEAMILEAIGVDFIDESEVLTPADEEHHI 115
M. tuberculosis RVPADIRAQGGVSRMSDPDMIEGIISAVTIPVMAKARIGHFVEAQILQSLGVDYIDESEVLTPADYTHHI 125
↑ ↑ ↑ ↑ ↑ ↑
L82/K84 M103 D105 S107 H118
α4 β5 α5 β6 α6 α6’
o^^ o^ o^^ o^ o^ o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^o^o^ o^^ o^ o^o^
P. falciparum DKHKFKTPFVCGCTNLGEALRRISEGASMIRTKGEA.GTGNIIEAIKHIRTVNNEIKYLCS.L.SDEEVY 185
P. berghei NKHKFKTPFVCGCTNLGEALRRISEGASMIRTKGEA.GTGNIIEAIKHIRTVNNEIKYLCS.L.DESEVY 186
P. chabaudi NKHKFKTPFVCGCTNLGEALRRISEGASMIRTKGEA.GTGNIIEGIKHIRTVNNEIKYLCS.L.DESEVY 186
P. knowlensi DKHKFKTPFVCGCTNLGEALRRISEGASMIRTKGEA.GTGNIIQAIKHIRTVKNEINYLCA.L.NENEVY 186
P. vivax DKHKFKTPFVCGCTNLGEALRRISEGASMIRTKGEA.GTGNIIQAIKHVRTVRNEINYLCA.L.SESEVY 192
A. thaliana 1.1 NKHNFKIPFVCGCRNLGEALRRIREGAAMIRTKGEA.GTGNVVEAVRHVRSVNGAIRLLRS.M.DDDEVF 200
A. thaliana 1.2 NKHNFRSPFICGCRDTGEALRRIREGAAMIRIQGDLTATGNIAETVKNVRSLMGEVRVLNN.M.DDDEVF 204
A. thaliana 1.3 NKHNFRIPFVCGCRNLGEALRRIREGAAMIRTKGEA.GTGNIIEAVRHVRSVNGDIRVLRN.M.DDDEVF 199
S. cerevisiae 1.1 EKDKFKVPFVCGAKDLGEALRRINEGAAMIRTKGEA.GTGDVSEAVKHIRRITEEIKACQQ.LKSEDDIA 183
S. cerevisiae 1.2 EKHNFKVPFVCGAKDLGEALRRINEGAAMIRTKGEA.GTGDVSEAVKHITKIKAEIQQYKENLKTESDFA 182
S. cerevisiae 1.3 EKHNFKVPFVCGAKDLGEALRRINEGAAMIRTKGEA.GTGDVSEAVKHITKIKAEIQQYKENLKTESDFA 182
T. gondii LKEKFSVPFVCGCRNLGEALRRVAEGASMIRTKGEA.GTGNIVEAVRHIRTVNREVALLRA.L.DEEEVF 192
B. subtilis NKNEYTVPFVCGCRDLGEATRRIAEGASMLRTKGEP.GTGNIVEAVRHMRKVNAQVRKVVA.M.SEDELM 183
G. stereaothermophilus DKRQFTVPFVCGCRDLGEAARRIAEGASMLRTKGEP.GTGNIVEAVRHMRKVNAQIRKVVS.M.SEDELV 183
T. maritima NKHEFKVPFVCGARDLGEALRRIAEGAAMIRTKGEA.GTGNVVEAVKHMRRVMEQIKQVTK.M.EDEELV 184
T. thermophilus DKWKFKVPFVCGARNLGEALRRIAEGAAMIRTKGEA.GTGNVVEAVRHARTMWKEIRYVQS.L.REDELM 182
M. tuberculosis DKWKFTVPFVCGATNLGEALRRINEGAAMIRSKGEA.GTGDVSNATTHMRAIGGEIRRLMS.L.SEDELY 192
↑ ↑ ↑↑ ↑ ↑ ↑ ↑
V129 R129 R140/141 M148/R150/K152/G156
α6’ α6” β7 α7 β8 α8’ α8
o^^ o^ o^ o^o^ o^^ o^ o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^o^o^ o^^ o^ o^ o^^ o^ o^o^o^o^o^o^o^
P. falciparum HFAKKINAPIDLVLLTKKLKRLPVVNFAAGGVATPADAAMCMQLGMDGVFVGSGIFESENPRKMAASIVS 255
P. berghei NFAKKLRAPIDLILLTRKLKRLPVVNFAAGGIATPADAAMCMQLGMDGVFVGSGIFESENPQKMASSIVM 256
P. chabaudi NFAKKLRAPIDLILLTRKLKRLPVVNFAAGGIATPADAAMCMQLGMDGVFVGSGIFESENPQKMASSIVM 256
P. knowlensi NYAKRINAPLDLVLLTRKLKKLPVVNFAAGGVATPADAAMCMQLGMDGVFVGSGIFESENPKKMATSIVA 256
P. vivax NYAKRISAPLDLLLLTRKLKKLPVVNFAAGGVATPADAAMCMQLGMDGVFVGSGIFESENPRRMATSIVA 262
A. thaliana 1.1 TYAKKIAAPYDLVVQTKELGRLPVVQFAAGGVATPADAALMMQLGCDGVFVGSGVFKSGDPVKRAKAIVQ 270
A. thaliana 1.2 TFAKKISAPYDLVAQTKQMGRVPVVQFASGGITTPADAALMMQLGCDGVFVGSEVFDGPDPFKKLRSIVQ 274
A. thaliana 1.3 TFAKKLAAPYDLVMQTKQLGRLPVVQFAAGGVATPADAALMMQLGCDGVFVGSGIFKSGDPARRARAIVQ 269
S. cerevisiae 1.1 KVAEEMRVPVSLLKDVLEKGKLPVVNFAAGGVATPADAALLMQLGCDGVFVGSGIFKSSNPVRLATAVVE 253
S. cerevisiae 1.2 AKATELRVPVDLLKTTLSEGKLPVVNFAAGGVATPADAALLMQLGCEGVFVGSGIFKSSDPEKLACAIVE 252
S. cerevisiae 1.3 AKATELRVPVDLLKTTLSEGKLPVVNFAAGGVATPADAALLMQLGCEGVFVGSGIFKSSDPEKLACAIVE 252
T. gondii SFAKQIQAPLALVEETRRLGRLPVVNFAAGGVATPADAALCMQLGVDGAFVGSGIFKSQCPEKTARAIVE 262
B. subtilis TEAKNLGAPYELLLQIKKDGKLPVVNFAAGGVATPADAALMMQLGADGVFVGSGIFKSDNPAKFAKAIVE 253
G. stereaothermophilus AEAKQLGAPVEVLREIKRIGRLPVVNFAAGGVATPADAALMMHLGADGVFVGSGIFKSENPEKYARAIVE 253
T. maritima AYGKEIGAPVELLREVKRLGRLPVVNFAAGGVATPADAALMMMLGADGVFVGSGIFKSKDPRKMAKAMVL 254
T. thermophilus AYAKEIGAPFELVKWVHDHGRLPVVNFAAGGIATPADAALMMHLGMDGVFVGSGIFKSGDPRKRARAIVR 252
M. tuberculosis VAAKELQAPYELVVEVARAGKLPVTLFTAGGIATPADAAMMMQLGAEGVFVGSGIFKSGDPAQRAAAIVK 262
↑ ↑ ↑ ↑ ↑↑
K190 F213 G217 F236/G238/S239
α8 α8”
o^^ o^ o^ o^ o^^ o^ o^o^o^o^ ↓ ↓ ↓ ↓ ↓ ↓
P. falciparum AVSNFNNPKILLDVSMNLGKAMCGSTR.VSDKWKN....KNEEHTKFLTPQ 301
P. berghei AVSNFNNPKILLNVSLGLGKAMHGNTK.VSNKWKN....KSEEDNS..... 297
P. chabaudi AVSNFNNPKILLNVSLGLGKAMHGNTK.VSNKWKN....KSEEDNS..... 297
P. knowlensi AVSNFNNPKILLNVSLNLGRAMCGSTT.ICQKWKN....KNEELN...... 296
P. vivax AVSNFNNPKILLNVSLNLGKAMCGSTT.ICEKWKN....KNEELN...... 302
A. thaliana 1.1 AVTNYRDAAVLAEVSCGLGEAMVGLNLDD.KVERFAS..RSE......... 309
A. thaliana 1.2 AVQHYNDPHVLAEMSSGLENAMESLNVRGDRIQDFG.....QGSV...... 314
A. thaliana 1.3 AVTHYSDPEMLVEVSCGLGEAMVGINLNDEKVERFAN..RSE......... 309
S. cerevisiae 1.1 ATTHFDNPSKLLEVSSDLGELMGGVSIESISHAS..NGVRLSEIGW..... 297
S. cerevisiae 1.2 ATTHYDNPAKLLQISSDLGDLMGGISIQSINEAGGKNGARLSEIGW..... 298
S. cerevisiae 1.3 ATTHYDNPAKLLQVSSDLGDLMGGISIQSINEAGGKNGARLSEIGW..... 298
T. gondii AVTHFDDAGHLAQVSRNLGEAMPGLTMDRIERWAG....RDTSLSSSIV.. 307
B. subtilis ATTHFTDYKLIAELSKELGTAMKGIEISNLLPEQ.....RMQERGW..... 294
G. stereaothermophilus ATTHYEDYELIAHLSKGLGGAMRGIDVATLLPEH.....RMQERGW..... 294
T. maritima AVTYWDNPRILLKISEDIGEPMRGLDVEEL..EV.....RMQERGW..... 293
T. thermophilus AVAHYNDPEVLAEVSEDLGEPMVGINLDQLKEEE.....RLAKRGW..... 293
M. tuberculosis ATTFYDDPDVLAKVSRGLGEAMVGINVEQIAQPE.....RLAERGW..... 303︸ ︷︷ ︸
C-terminus
Figure D.2: Alignment of amino acid sequences of selected Pdx2 proteins. Residues in dark blue correspond to the
residues at the interface with Pdx1 in the Pdx1/2 complexes from B. subtilis, T. maritima and chimera P. berghei
Pdx1/ P. falciparum Pdx2. Residues involved in catalysis: triad catalytic (C87, H196 and E198), Q12, R121, R154,
E53 and oxyanion hole peptide (P50, G51 and G52) are enumerated in the alignment based on P. falciparum Pdx2
protein.
β1 α1 β2 α2 β3
o^^ o^ o^ o^o^o^o^o^o^ o^^ o^ o^o^
P. falciparum Pdx2 .......MSE...ITIGVLSLQGDFEPHINHFIKLQI.PSLNII......QVRNVHDLGLCDGLV 48
P. berghei Pdx2 .......MEK...LTIGVLSLQGNFQSHINHFLQLQN.PSLKVI......EVRNKTNLRECDGIV 48
P. knowlesi Pdx2 .......MAD...ITIGVLSLQGDFQPHIKHLNKLEQ.PNLRVI......EVRNIKDLSTCDGLV 48
P. vivax Pdx2 .......MAD...ITIGVLSLQGDFQPHINHFQKLEE.PGLKVV......EVRNKEDLSTCDGLV 48
A. thaliana Pdx2 .............MTVGVLALQGSFNEHIAALRRLGVQGV..........EIRKADQLLTVSSLI 42
S. cerevisiae Pdx2.1 MHKTHSTMSGKSMKVIGVLALQGAFLEHTNHLKRCLAEND..YGIKIEIKTVKTPEDLAQCDALI 63
S. cerevisiae Pdx2.2 .......MT....VVIGVLALQGAFIEHVRHVEKCIVENRDFYEKKLSVMTVKDKNQLAQCDALI 54
S. cerevisiae Pdx2.3 .......MT....VVIGVLALQGAFIEHVRHVEKCIVENRDFYEKKLSVMTVKDKNQLAQCDALI 54
T. gondii Pdx2 .......MGEERPVCLGVLALQGAFFDHIKSFKRLNLGTRLRLT......LVKKPADLEEIDALV 52
B. subtilis Pdx2 ............MLTIGVLGLQGAVREHIHAIEACGAAGL..........VVKRPEQLNEVDGLI 43
G. stearothermophilus Pdx2 .............MKIGVLGLQGAVREHVRAIEACGAEAV..........IVKKSEQLEGLDGLV 42
T. maritima Pdx2 .............MKIGVLGVQGDVREHVEALHKLGVETL..........IVKLPEQLDMVDGLI 42
T. thermophilus Pdx2 ...........MRGVVGVLALQGDFREHKEALKRLGIEAK..........EVRKKEHLEGLKALI 44
M. tuberculosis Pdx2 ..........MSVPRVGVLALQGDTREHLAALRECGAEPM..........TVRRRDELDAVDALV 45
↑
Q12
β3 E53 α3 α4 β4 α5 β5
↑ o^^ o^ o^ o^o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^o^o^o^o^o^ o^^ o^ o^o^o^o^o^
P. falciparum Pdx2 IPGGESTTVRRCCAYENDTLYNALVHFIHVLKKPIWGTCAGCILLSKNVENIK...........L 102
P. berghei Pdx2 IPGGESTTLRKCMSYDNDSLYNALKNYIHVKKKPVWGTCAGCILLSEKVEKNKDD.........N 104
P. knowlesi Pdx2 IPGGESTTLRKCFAYDNDALYNALKEFIHIKKKPVWGTCAGCILLSNNVENNE...........T 102
P. vivax Pdx2 IPGGESTTLRKCFAYDNDALYNALKEFIHVKKKPVWGTCAGCILLSNNVENNE...........T 102
A. thaliana Pdx2 IPGGESTTMA..KLAEYHNLFPALREFVKMG.KPVWGTCAGLIFLADRAVGQ.KE.......... 93
S. cerevisiae Pdx2.1 IPGGESTSMS..LIAQRTGLYPCLYEFVHNPEKVVWGTCAGLIFLSAQLENE............. 113
S. cerevisiae Pdx2.2 IPGGESTAMS..LIAERTGFYDDLYAFVHNPSKVTWGTCAGMIYISQQLSNE............. 104
S. cerevisiae Pdx2.3 IPGGESTAMS..LIAERTGFYDDLYAFVHNPSKVTWGTCAGLIYISQQLSNE............. 104
T. gondii Pdx2 IPGGESTAMR...IIAGEEMMSALQAFVHEKKKPVWGTCAGCILLSNTVCTLETSSSPSASEIRE 114
B. subtilis Pdx2 LPGGESTTMR..RLIDTYQFMEPLREFAAQG.KPMFGTCAGLIILAKEIAGS............. 92
G. stearothermophilus Pdx2 LPGGESTTXR..RLIDRYGLXEPLKQFAAAG.KPXFGTCAGLILLAKRIVGY............. 91
T. maritima Pdx2 LPGGESTTMI..RILKEMDMDEKLVERINNG.LPVFATCAGVILLAKRIKNY............. 91
T. thermophilus Pdx2 VPGGESTTIG..KLAREYGIEDEVRKRVEEGSLALFGTCAGAIWLAKEIVGY............. 94
M. tuberculosis Pdx2 IPGGESTTMS..HLLLDLDLLGPLRARLADG.LPAYGSCAGMILLASEILDAGAA.......... 97︸︷︷︸ ↑ ︸ ︷︷ ︸
oxyanion hole peptide (P50/G51/G52) C87 Loop 95-111
α5-1 β6 β7 β8 β9
o^^ o^ o^ o^
P. falciparum Pdx2 YSN.FGNKFSFGGLDITICRNFYGSQNDSFICSLNIISDSS..AFKKDLTAACIRAPYIREILSD 164
P. berghei Pdx2 IENEYGNDFSLGGLDIEITRNYYGSQNDSFICSLDIKSQDP..IFKKNIRAPCIRAPFIKKISSD 167
P. knowlesi Pdx2 QSKAYGKNFSLGGLDITISRNYYGSQNDSFICSLNVHSENS..AFKKNLRGACIRAPYIKEIHSD 165
P. vivax Pdx2 QSQAYGKNFSLGGLDITISRNFYGSQNDSFICSLNVHSESS..AFKKNLRGACIRAPYIREIHSD 165
A. thaliana Pdx2 ....GGQEL.VGGLDCTVHRNFFGSQIQSFEADILVPQLTSQEGGPETYRGVFIRAPAVLDVGPD 153
S. cerevisiae Pdx2.1 ....SALVKTLGVLKVDVRRNAFGRQAQSFTQKCDFSNFIP...GCDNFPATFIRAPVIERILDP 171
S. cerevisiae Pdx2.2 ....EKLVKTLNLLKVKVKRNAFGRQAQSSTRICDFSNFIP...HCNDFPATFIRAPVIEEVLDP 162
S. cerevisiae Pdx2.3 ....AKLVKTLNLLKVKVKRNAFGRQAQSSTRICDFSNFIP...HCNDFPATFIRAPVIEEVLDP 162
T. gondii Pdx2 TPSDDGYGDFIGGAAVRTCRNFFGRQVDSFEAPLRAVGRLK..IAADGMHAICIRAPAIVDVSP. 176
B. subtilis Pdx2 ......DNPHLGLLNVVVERNSFGRQVDSFEADLTIKGLD......EPFTGVFIRAPHILEAGEN 145
G. stearothermophilus Pdx2 ......DEPHLGLXDITVERNSFGRQRESFEAELSIKGVG......DGFVGVFIRAPHIVEAGDG 144
T. maritima Pdx2 ......SQEKLGVLDITVERNAYGRQVESFETFVEIPAVGK.....DPFRAIFIRAPRIVETGKN 145
T. thermophilus Pdx2 .....PEQPRLGVLEAWVERNAFGRQVESFEEDLEVEGLG.......SFHGVFIRAPVFRRLGEG 147
M. tuberculosis Pdx2 ....GRQALPLRAMNMTVRRNAFGSQVDSFEGDIEFAGLD......DPVRAVFIRAPWVERVGDG 152︸ ︷︷ ︸ ↑ ↑
Loop 95-111 R121 R154
β10 β11 β12 α6-1 α6
o^^ o^ o^ o^^ o^ o^o^o^o^o^
P. falciparum Pdx2 EVKVLATFSHES..................YGPNIIAAVEQNNCLGTVFHPELLP.HTAFQQYFY 210
P. berghei Pdx2 KVVTIATFSHES..................FGKNIIGAVEQDNCMGTIFHPELMP.YTCFHDYFL 213
P. knowlesi Pdx2 QIHTLATFSHEP..................FGSNIIAAVEQNNCLGMVFHPELMP.YNSFHQYFY 211
P. vivax Pdx2 QVHTLATFSHET..................VGPNIIAAVEQNNCLGMVFHPELMP.HSSFHQYFY 211
A. thaliana Pdx2 VEVLADYPVPSNKVLYSSSTVQIQEEDALPETKVIVAVKQ.GNLLATAFHPELTA.DTRWHSYFI 216
S. cerevisiae Pdx2.1 IAVKSLYELPVN..................GKDVVVAATQNHNILVTSFHPELADSDTRFHDWFI 218
S. cerevisiae Pdx2.2 EHVQVLYKLDGKDN...............GGQELIVAAKQKNNILATSFHPELAENDIRFHDWFI 212
S. cerevisiae Pdx2.3 EHVQVLYKLDGKDN...............GGQELIVAAKQKNNILATSFHPELAENDIRFHDWFI 212
T. gondii Pdx2 EVEVLAYIDLPG..................RHTSVIAAAAHGPLLLTIFHPELTN.DTRLHAFFL 222
B. subtilis Pdx2 VEVLSE........................HNGRIVAAKQ.GQFLGCSFHPELTE.DHRVTQLFV 184
G. stearothermophilus Pdx2 VDVLAT........................YNDRIVAARQ.GQFLGCSFHPELTD.DHRLXQYFL 183
T. maritima Pdx2 VEILAT........................YDYDPVLVKE.GNILACTFHPELTD.DLRLHRYFL 184
T. thermophilus Pdx2 VEVLAR........................LGDLPVLVRQ.GKVLASSFHPELTE.DPRLHRYFL 186
M. tuberculosis Pdx2 VQVLAR........................AAGHIVAVRQ.GAVLATAFHPEMTG.DRRIHQLFV 191
↑ ↑
H196/E198
α6
o^^ o^ o^ o^o^o^o^o^o^o^o^o^o^o^o^o^o^
P. falciparum Pdx2 E...........KVKNYKYS.......................................... 219
P. berghei Pdx2 E...........KVKKHIKDSREA...................................... 226
P. knowlesi Pdx2 E...........KVKNSKK........................................... 219
P. vivax Pdx2 E...........KVKNSKK........................................... 219
A. thaliana Pdx2 K...........MTKEIEQGASSSSSKTIVSVGETSAGPEPAKPDLPIFQ............ 255
S. cerevisiae Pdx2.1 R...........QFVSN............................................. 224
S. cerevisiae Pdx2.2 R...........EFVLKNYSK......................................... 222
S. cerevisiae Pdx2.3 R...........EFVLKNYSK......................................... 222
T. gondii Pdx2 DNFVFPALGRASSAKATKREVEASGARNSEPSVSFPNGERRVSERAQAAQDAKSPQLGIRSS 284
B. subtilis Pdx2 E...........MVEEYKQKALV....................................... 196
G. stearothermophilus Pdx2 N...........XVKEAKXASSLK...................................... 196
T. maritima Pdx2 E...........MVK............................................... 188
T. thermophilus Pdx2 E...........LAGV.............................................. 191
M. tuberculosis Pdx2 D...........IVTSAA............................................ 198
78
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